context stringlengths 21 33.9k | category stringclasses 2
values | entity stringlengths 1 12 | entity_type stringclasses 5
values | query stringlengths 97 3.31k | answer stringlengths 12 169 |
|---|---|---|---|---|---|
As of December 31, 2024 and 2023, the Company had open Service Contract Hedging contracts to hedge certain forecasted foreign currency cash flow transactions occurring in 2025 and 2024 with notional amounts totaling $ 108 million and $ 121 million, respectively. For accounting purposes these hedges are considered highly effective. As of December 31, 2024 and 2023, the Company had recorded gross unrealized gains (losses) of $ — million and $( 2 ) million, and $ 2 million and $ — million, respectively, related to these contracts. Upon expiration of the hedge instruments in 2024, the Company reclassified the unrealized holding gains and losses on the derivative instruments included in AOCI into earnings. The unrealized gains (losses) are included in other current assets and other current liabilities on the accompanying consolidated balance sheets as of December 31, 2024 and 2023. | text | 121 | monetaryItemType | text: <entity> 121 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the Company had open Service Contract Hedging contracts to hedge certain forecasted foreign currency cash flow transactions occurring in 2025 and 2024 with notional amounts totaling $ 108 million and $ 121 million, respectively. For accounting purposes these hedges are considered highly effective. As of December 31, 2024 and 2023, the Company had recorded gross unrealized gains (losses) of $ — million and $( 2 ) million, and $ 2 million and $ — million, respectively, related to these contracts. Upon expiration of the hedge instruments in 2024, the Company reclassified the unrealized holding gains and losses on the derivative instruments included in AOCI into earnings. The unrealized gains (losses) are included in other current assets and other current liabilities on the accompanying consolidated balance sheets as of December 31, 2024 and 2023. </context> | us-gaap:DerivativeNotionalAmount |
As of December 31, 2024 and 2023, the Company had open Service Contract Hedging contracts to hedge certain forecasted foreign currency cash flow transactions occurring in 2025 and 2024 with notional amounts totaling $ 108 million and $ 121 million, respectively. For accounting purposes these hedges are considered highly effective. As of December 31, 2024 and 2023, the Company had recorded gross unrealized gains (losses) of $ — million and $( 2 ) million, and $ 2 million and $ — million, respectively, related to these contracts. Upon expiration of the hedge instruments in 2024, the Company reclassified the unrealized holding gains and losses on the derivative instruments included in AOCI into earnings. The unrealized gains (losses) are included in other current assets and other current liabilities on the accompanying consolidated balance sheets as of December 31, 2024 and 2023. | text | — million | monetaryItemType | text: <entity> — million </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the Company had open Service Contract Hedging contracts to hedge certain forecasted foreign currency cash flow transactions occurring in 2025 and 2024 with notional amounts totaling $ 108 million and $ 121 million, respectively. For accounting purposes these hedges are considered highly effective. As of December 31, 2024 and 2023, the Company had recorded gross unrealized gains (losses) of $ — million and $( 2 ) million, and $ 2 million and $ — million, respectively, related to these contracts. Upon expiration of the hedge instruments in 2024, the Company reclassified the unrealized holding gains and losses on the derivative instruments included in AOCI into earnings. The unrealized gains (losses) are included in other current assets and other current liabilities on the accompanying consolidated balance sheets as of December 31, 2024 and 2023. </context> | us-gaap:ForeignCurrencyTransactionGainBeforeTax |
As of December 31, 2024 and 2023, the Company had open Service Contract Hedging contracts to hedge certain forecasted foreign currency cash flow transactions occurring in 2025 and 2024 with notional amounts totaling $ 108 million and $ 121 million, respectively. For accounting purposes these hedges are considered highly effective. As of December 31, 2024 and 2023, the Company had recorded gross unrealized gains (losses) of $ — million and $( 2 ) million, and $ 2 million and $ — million, respectively, related to these contracts. Upon expiration of the hedge instruments in 2024, the Company reclassified the unrealized holding gains and losses on the derivative instruments included in AOCI into earnings. The unrealized gains (losses) are included in other current assets and other current liabilities on the accompanying consolidated balance sheets as of December 31, 2024 and 2023. | text | 2 | monetaryItemType | text: <entity> 2 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the Company had open Service Contract Hedging contracts to hedge certain forecasted foreign currency cash flow transactions occurring in 2025 and 2024 with notional amounts totaling $ 108 million and $ 121 million, respectively. For accounting purposes these hedges are considered highly effective. As of December 31, 2024 and 2023, the Company had recorded gross unrealized gains (losses) of $ — million and $( 2 ) million, and $ 2 million and $ — million, respectively, related to these contracts. Upon expiration of the hedge instruments in 2024, the Company reclassified the unrealized holding gains and losses on the derivative instruments included in AOCI into earnings. The unrealized gains (losses) are included in other current assets and other current liabilities on the accompanying consolidated balance sheets as of December 31, 2024 and 2023. </context> | us-gaap:ForeignCurrencyTransactionLossBeforeTax |
As of December 31, 2024 and 2023, the Company had open Service Contract Hedging contracts to hedge certain forecasted foreign currency cash flow transactions occurring in 2025 and 2024 with notional amounts totaling $ 108 million and $ 121 million, respectively. For accounting purposes these hedges are considered highly effective. As of December 31, 2024 and 2023, the Company had recorded gross unrealized gains (losses) of $ — million and $( 2 ) million, and $ 2 million and $ — million, respectively, related to these contracts. Upon expiration of the hedge instruments in 2024, the Company reclassified the unrealized holding gains and losses on the derivative instruments included in AOCI into earnings. The unrealized gains (losses) are included in other current assets and other current liabilities on the accompanying consolidated balance sheets as of December 31, 2024 and 2023. | text | 2 | monetaryItemType | text: <entity> 2 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the Company had open Service Contract Hedging contracts to hedge certain forecasted foreign currency cash flow transactions occurring in 2025 and 2024 with notional amounts totaling $ 108 million and $ 121 million, respectively. For accounting purposes these hedges are considered highly effective. As of December 31, 2024 and 2023, the Company had recorded gross unrealized gains (losses) of $ — million and $( 2 ) million, and $ 2 million and $ — million, respectively, related to these contracts. Upon expiration of the hedge instruments in 2024, the Company reclassified the unrealized holding gains and losses on the derivative instruments included in AOCI into earnings. The unrealized gains (losses) are included in other current assets and other current liabilities on the accompanying consolidated balance sheets as of December 31, 2024 and 2023. </context> | us-gaap:ForeignCurrencyTransactionGainBeforeTax |
As of December 31, 2024 and 2023, the Company had open Service Contract Hedging contracts to hedge certain forecasted foreign currency cash flow transactions occurring in 2025 and 2024 with notional amounts totaling $ 108 million and $ 121 million, respectively. For accounting purposes these hedges are considered highly effective. As of December 31, 2024 and 2023, the Company had recorded gross unrealized gains (losses) of $ — million and $( 2 ) million, and $ 2 million and $ — million, respectively, related to these contracts. Upon expiration of the hedge instruments in 2024, the Company reclassified the unrealized holding gains and losses on the derivative instruments included in AOCI into earnings. The unrealized gains (losses) are included in other current assets and other current liabilities on the accompanying consolidated balance sheets as of December 31, 2024 and 2023. | text | — | monetaryItemType | text: <entity> — </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024 and 2023, the Company had open Service Contract Hedging contracts to hedge certain forecasted foreign currency cash flow transactions occurring in 2025 and 2024 with notional amounts totaling $ 108 million and $ 121 million, respectively. For accounting purposes these hedges are considered highly effective. As of December 31, 2024 and 2023, the Company had recorded gross unrealized gains (losses) of $ — million and $( 2 ) million, and $ 2 million and $ — million, respectively, related to these contracts. Upon expiration of the hedge instruments in 2024, the Company reclassified the unrealized holding gains and losses on the derivative instruments included in AOCI into earnings. The unrealized gains (losses) are included in other current assets and other current liabilities on the accompanying consolidated balance sheets as of December 31, 2024 and 2023. </context> | us-gaap:ForeignCurrencyTransactionLossBeforeTax |
As of December 31, 2024, the portion of the Company's foreign currency denominated debt balance that was designated as a hedge of its net investment in certain foreign subsidiaries totaled approximately € 2,732 million ($ 2,837 million). The amount of foreign exchange gains (losses) related to this net investment hedge included in the cumulative translation adjustment component of AOCI was $ 186 million, $( 102 ) million, and $ 332 million for the years ended December 31, 2024, 2023 and 2022, respectively. | text | 2732 | monetaryItemType | text: <entity> 2732 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the portion of the Company's foreign currency denominated debt balance that was designated as a hedge of its net investment in certain foreign subsidiaries totaled approximately € 2,732 million ($ 2,837 million). The amount of foreign exchange gains (losses) related to this net investment hedge included in the cumulative translation adjustment component of AOCI was $ 186 million, $( 102 ) million, and $ 332 million for the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:LongTermDebt |
As of December 31, 2024, the portion of the Company's foreign currency denominated debt balance that was designated as a hedge of its net investment in certain foreign subsidiaries totaled approximately € 2,732 million ($ 2,837 million). The amount of foreign exchange gains (losses) related to this net investment hedge included in the cumulative translation adjustment component of AOCI was $ 186 million, $( 102 ) million, and $ 332 million for the years ended December 31, 2024, 2023 and 2022, respectively. | text | 2837 | monetaryItemType | text: <entity> 2837 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the portion of the Company's foreign currency denominated debt balance that was designated as a hedge of its net investment in certain foreign subsidiaries totaled approximately € 2,732 million ($ 2,837 million). The amount of foreign exchange gains (losses) related to this net investment hedge included in the cumulative translation adjustment component of AOCI was $ 186 million, $( 102 ) million, and $ 332 million for the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:LongTermDebt |
As of December 31, 2024, the portion of the Company's foreign currency denominated debt balance that was designated as a hedge of its net investment in certain foreign subsidiaries totaled approximately € 2,732 million ($ 2,837 million). The amount of foreign exchange gains (losses) related to this net investment hedge included in the cumulative translation adjustment component of AOCI was $ 186 million, $( 102 ) million, and $ 332 million for the years ended December 31, 2024, 2023 and 2022, respectively. | text | 186 | monetaryItemType | text: <entity> 186 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the portion of the Company's foreign currency denominated debt balance that was designated as a hedge of its net investment in certain foreign subsidiaries totaled approximately € 2,732 million ($ 2,837 million). The amount of foreign exchange gains (losses) related to this net investment hedge included in the cumulative translation adjustment component of AOCI was $ 186 million, $( 102 ) million, and $ 332 million for the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:TranslationAdjustmentForNetInvestmentHedgeNetOfTax |
As of December 31, 2024, the portion of the Company's foreign currency denominated debt balance that was designated as a hedge of its net investment in certain foreign subsidiaries totaled approximately € 2,732 million ($ 2,837 million). The amount of foreign exchange gains (losses) related to this net investment hedge included in the cumulative translation adjustment component of AOCI was $ 186 million, $( 102 ) million, and $ 332 million for the years ended December 31, 2024, 2023 and 2022, respectively. | text | 102 | monetaryItemType | text: <entity> 102 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the portion of the Company's foreign currency denominated debt balance that was designated as a hedge of its net investment in certain foreign subsidiaries totaled approximately € 2,732 million ($ 2,837 million). The amount of foreign exchange gains (losses) related to this net investment hedge included in the cumulative translation adjustment component of AOCI was $ 186 million, $( 102 ) million, and $ 332 million for the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:TranslationAdjustmentForNetInvestmentHedgeNetOfTax |
As of December 31, 2024, the portion of the Company's foreign currency denominated debt balance that was designated as a hedge of its net investment in certain foreign subsidiaries totaled approximately € 2,732 million ($ 2,837 million). The amount of foreign exchange gains (losses) related to this net investment hedge included in the cumulative translation adjustment component of AOCI was $ 186 million, $( 102 ) million, and $ 332 million for the years ended December 31, 2024, 2023 and 2022, respectively. | text | 332 | monetaryItemType | text: <entity> 332 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the portion of the Company's foreign currency denominated debt balance that was designated as a hedge of its net investment in certain foreign subsidiaries totaled approximately € 2,732 million ($ 2,837 million). The amount of foreign exchange gains (losses) related to this net investment hedge included in the cumulative translation adjustment component of AOCI was $ 186 million, $( 102 ) million, and $ 332 million for the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:TranslationAdjustmentForNetInvestmentHedgeNetOfTax |
, the Company entered into cross-currency swaps with a combined notional value of $ 1,250 million to effectively convert $ 1,250 million of the 2029 Senior Secured Notes into euro-denominated borrowings at prevailing euro interest rates through February 2029. The Company designated these agreements as a hedge of its net investment in certain foreign subsidiaries. These cross-currency swaps expire in February 2029. The Company will receive semiannual interest payments on February 1 and August 1 from the counterparties based on a fixed interest rate until maturity of these agreements. The effective net borrowing rate to the Company is approximately 4.8555 %, inclusive of the yield on the notes and the impact of the cross-currency swaps. | text | 1250 | monetaryItemType | text: <entity> 1250 </entity> <entity type> monetaryItemType </entity type> <context> , the Company entered into cross-currency swaps with a combined notional value of $ 1,250 million to effectively convert $ 1,250 million of the 2029 Senior Secured Notes into euro-denominated borrowings at prevailing euro interest rates through February 2029. The Company designated these agreements as a hedge of its net investment in certain foreign subsidiaries. These cross-currency swaps expire in February 2029. The Company will receive semiannual interest payments on February 1 and August 1 from the counterparties based on a fixed interest rate until maturity of these agreements. The effective net borrowing rate to the Company is approximately 4.8555 %, inclusive of the yield on the notes and the impact of the cross-currency swaps. </context> | us-gaap:DebtInstrumentCarryingAmount |
, the Company entered into cross-currency swaps with a combined notional value of $ 1,250 million to effectively convert $ 1,250 million of the 2029 Senior Secured Notes into euro-denominated borrowings at prevailing euro interest rates through February 2029. The Company designated these agreements as a hedge of its net investment in certain foreign subsidiaries. These cross-currency swaps expire in February 2029. The Company will receive semiannual interest payments on February 1 and August 1 from the counterparties based on a fixed interest rate until maturity of these agreements. The effective net borrowing rate to the Company is approximately 4.8555 %, inclusive of the yield on the notes and the impact of the cross-currency swaps. | text | 4.8555 | percentItemType | text: <entity> 4.8555 </entity> <entity type> percentItemType </entity type> <context> , the Company entered into cross-currency swaps with a combined notional value of $ 1,250 million to effectively convert $ 1,250 million of the 2029 Senior Secured Notes into euro-denominated borrowings at prevailing euro interest rates through February 2029. The Company designated these agreements as a hedge of its net investment in certain foreign subsidiaries. These cross-currency swaps expire in February 2029. The Company will receive semiannual interest payments on February 1 and August 1 from the counterparties based on a fixed interest rate until maturity of these agreements. The effective net borrowing rate to the Company is approximately 4.8555 %, inclusive of the yield on the notes and the impact of the cross-currency swaps. </context> | us-gaap:DerivativeVariableInterestRate |
, the Company entered into cross-currency swaps with a combined notional value of $ 1,500 million to effectively convert $ 1,500 million of the Term B-4 Dollar Loans into euro-denominated borrowings at prevailing euro interest rates through January 2031. These cross-currency swaps expire in January 2031. The Company will receive quarterly interest payments from the counterparties based on a fixed interest rate until maturity of these agreements. The effective net borrowing rate to the Company is approximately 4.9015 %, inclusive of the yield on the loans, the impact of the cross-currency swaps and of the interest rate swaps entered o | text | 1500 | monetaryItemType | text: <entity> 1500 </entity> <entity type> monetaryItemType </entity type> <context> , the Company entered into cross-currency swaps with a combined notional value of $ 1,500 million to effectively convert $ 1,500 million of the Term B-4 Dollar Loans into euro-denominated borrowings at prevailing euro interest rates through January 2031. These cross-currency swaps expire in January 2031. The Company will receive quarterly interest payments from the counterparties based on a fixed interest rate until maturity of these agreements. The effective net borrowing rate to the Company is approximately 4.9015 %, inclusive of the yield on the loans, the impact of the cross-currency swaps and of the interest rate swaps entered o </context> | us-gaap:DebtInstrumentCarryingAmount |
, the Company entered into cross-currency swaps with a combined notional value of $ 1,500 million to effectively convert $ 1,500 million of the Term B-4 Dollar Loans into euro-denominated borrowings at prevailing euro interest rates through January 2031. These cross-currency swaps expire in January 2031. The Company will receive quarterly interest payments from the counterparties based on a fixed interest rate until maturity of these agreements. The effective net borrowing rate to the Company is approximately 4.9015 %, inclusive of the yield on the loans, the impact of the cross-currency swaps and of the interest rate swaps entered o | text | 4.9015 | percentItemType | text: <entity> 4.9015 </entity> <entity type> percentItemType </entity type> <context> , the Company entered into cross-currency swaps with a combined notional value of $ 1,500 million to effectively convert $ 1,500 million of the Term B-4 Dollar Loans into euro-denominated borrowings at prevailing euro interest rates through January 2031. These cross-currency swaps expire in January 2031. The Company will receive quarterly interest payments from the counterparties based on a fixed interest rate until maturity of these agreements. The effective net borrowing rate to the Company is approximately 4.9015 %, inclusive of the yield on the loans, the impact of the cross-currency swaps and of the interest rate swaps entered o </context> | us-gaap:DerivativeVariableInterestRate |
The Company does not enter into cross-currency swaps for investment or speculative purposes. For the years ended December 31, 2024 and 2023, the Company recorded gains (losses) of $ 147 million and $( 108 ) million, respectively, within AOCI as a result of these cross-currency swaps. The Company recognized $ 36 million and $ 3 million related to the excluded component as a reduction of interest expense for the years ended December 31, 2024 and | text | 147 | monetaryItemType | text: <entity> 147 </entity> <entity type> monetaryItemType </entity type> <context> The Company does not enter into cross-currency swaps for investment or speculative purposes. For the years ended December 31, 2024 and 2023, the Company recorded gains (losses) of $ 147 million and $( 108 ) million, respectively, within AOCI as a result of these cross-currency swaps. The Company recognized $ 36 million and $ 3 million related to the excluded component as a reduction of interest expense for the years ended December 31, 2024 and </context> | us-gaap:ForeignCurrencyTransactionLossBeforeTax |
The Company does not enter into cross-currency swaps for investment or speculative purposes. For the years ended December 31, 2024 and 2023, the Company recorded gains (losses) of $ 147 million and $( 108 ) million, respectively, within AOCI as a result of these cross-currency swaps. The Company recognized $ 36 million and $ 3 million related to the excluded component as a reduction of interest expense for the years ended December 31, 2024 and | text | 108 | monetaryItemType | text: <entity> 108 </entity> <entity type> monetaryItemType </entity type> <context> The Company does not enter into cross-currency swaps for investment or speculative purposes. For the years ended December 31, 2024 and 2023, the Company recorded gains (losses) of $ 147 million and $( 108 ) million, respectively, within AOCI as a result of these cross-currency swaps. The Company recognized $ 36 million and $ 3 million related to the excluded component as a reduction of interest expense for the years ended December 31, 2024 and </context> | us-gaap:ForeignCurrencyTransactionLossBeforeTax |
The Company expects $ 3 million of pre-tax unrealized gains related to its foreign exchange contracts and interest rate derivatives included in AOCI as of December 31, 2024 to be reclassified into earnings within the next twelve months. The total amount, net of income taxes, of the cash flow hedge effect on the accompanying consolidated statements of income was $ 31 million, $ 51 million, and $( 10 ) million for the years ended December 31, 2024, 2023 and 2022, respectively. | text | 3 | monetaryItemType | text: <entity> 3 </entity> <entity type> monetaryItemType </entity type> <context> The Company expects $ 3 million of pre-tax unrealized gains related to its foreign exchange contracts and interest rate derivatives included in AOCI as of December 31, 2024 to be reclassified into earnings within the next twelve months. The total amount, net of income taxes, of the cash flow hedge effect on the accompanying consolidated statements of income was $ 31 million, $ 51 million, and $( 10 ) million for the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:ForeignCurrencyCashFlowHedgeGainLossToBeReclassifiedDuringNext12Months |
The Company expects $ 3 million of pre-tax unrealized gains related to its foreign exchange contracts and interest rate derivatives included in AOCI as of December 31, 2024 to be reclassified into earnings within the next twelve months. The total amount, net of income taxes, of the cash flow hedge effect on the accompanying consolidated statements of income was $ 31 million, $ 51 million, and $( 10 ) million for the years ended December 31, 2024, 2023 and 2022, respectively. | text | 31 | monetaryItemType | text: <entity> 31 </entity> <entity type> monetaryItemType </entity type> <context> The Company expects $ 3 million of pre-tax unrealized gains related to its foreign exchange contracts and interest rate derivatives included in AOCI as of December 31, 2024 to be reclassified into earnings within the next twelve months. The total amount, net of income taxes, of the cash flow hedge effect on the accompanying consolidated statements of income was $ 31 million, $ 51 million, and $( 10 ) million for the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax |
The Company expects $ 3 million of pre-tax unrealized gains related to its foreign exchange contracts and interest rate derivatives included in AOCI as of December 31, 2024 to be reclassified into earnings within the next twelve months. The total amount, net of income taxes, of the cash flow hedge effect on the accompanying consolidated statements of income was $ 31 million, $ 51 million, and $( 10 ) million for the years ended December 31, 2024, 2023 and 2022, respectively. | text | 51 | monetaryItemType | text: <entity> 51 </entity> <entity type> monetaryItemType </entity type> <context> The Company expects $ 3 million of pre-tax unrealized gains related to its foreign exchange contracts and interest rate derivatives included in AOCI as of December 31, 2024 to be reclassified into earnings within the next twelve months. The total amount, net of income taxes, of the cash flow hedge effect on the accompanying consolidated statements of income was $ 31 million, $ 51 million, and $( 10 ) million for the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax |
The Company expects $ 3 million of pre-tax unrealized gains related to its foreign exchange contracts and interest rate derivatives included in AOCI as of December 31, 2024 to be reclassified into earnings within the next twelve months. The total amount, net of income taxes, of the cash flow hedge effect on the accompanying consolidated statements of income was $ 31 million, $ 51 million, and $( 10 ) million for the years ended December 31, 2024, 2023 and 2022, respectively. | text | 10 | monetaryItemType | text: <entity> 10 </entity> <entity type> monetaryItemType </entity type> <context> The Company expects $ 3 million of pre-tax unrealized gains related to its foreign exchange contracts and interest rate derivatives included in AOCI as of December 31, 2024 to be reclassified into earnings within the next twelve months. The total amount, net of income taxes, of the cash flow hedge effect on the accompanying consolidated statements of income was $ 31 million, $ 51 million, and $( 10 ) million for the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax |
The carrying values of cash, cash equivalents, accounts receivable and accounts payable approximated their fair values as of December 31, 2024 and 2023 due to their short-term nature. As of December 31, 2024 and 2023, the fair value of total debt was $ 13,966 million and $ 13,597 million, respectively, as determined under Level 2 measurements for these financial instruments. | text | 13966 | monetaryItemType | text: <entity> 13966 </entity> <entity type> monetaryItemType </entity type> <context> The carrying values of cash, cash equivalents, accounts receivable and accounts payable approximated their fair values as of December 31, 2024 and 2023 due to their short-term nature. As of December 31, 2024 and 2023, the fair value of total debt was $ 13,966 million and $ 13,597 million, respectively, as determined under Level 2 measurements for these financial instruments. </context> | us-gaap:DebtInstrumentFairValue |
The carrying values of cash, cash equivalents, accounts receivable and accounts payable approximated their fair values as of December 31, 2024 and 2023 due to their short-term nature. As of December 31, 2024 and 2023, the fair value of total debt was $ 13,966 million and $ 13,597 million, respectively, as determined under Level 2 measurements for these financial instruments. | text | 13597 | monetaryItemType | text: <entity> 13597 </entity> <entity type> monetaryItemType </entity type> <context> The carrying values of cash, cash equivalents, accounts receivable and accounts payable approximated their fair values as of December 31, 2024 and 2023 due to their short-term nature. As of December 31, 2024 and 2023, the fair value of total debt was $ 13,966 million and $ 13,597 million, respectively, as determined under Level 2 measurements for these financial instruments. </context> | us-gaap:DebtInstrumentFairValue |
Certain assets are carried on the accompanying consolidated balance sheets at cost and are not remeasured to fair value on a recurring basis. As of December 31, 2024, assets carried on the balance sheet and not remeasured to fair value on a recurring basis totaled $ 19,554 million and were identified as Level 3. These assets are comprised of debt investments and cost and equity method investments of $ 345 million, goodwill of $ 14,710 million and other identifiable intangibles, net of $ 4,499 million. | text | 19554 | monetaryItemType | text: <entity> 19554 </entity> <entity type> monetaryItemType </entity type> <context> Certain assets are carried on the accompanying consolidated balance sheets at cost and are not remeasured to fair value on a recurring basis. As of December 31, 2024, assets carried on the balance sheet and not remeasured to fair value on a recurring basis totaled $ 19,554 million and were identified as Level 3. These assets are comprised of debt investments and cost and equity method investments of $ 345 million, goodwill of $ 14,710 million and other identifiable intangibles, net of $ 4,499 million. </context> | us-gaap:AssetsFairValueDisclosure |
Certain assets are carried on the accompanying consolidated balance sheets at cost and are not remeasured to fair value on a recurring basis. As of December 31, 2024, assets carried on the balance sheet and not remeasured to fair value on a recurring basis totaled $ 19,554 million and were identified as Level 3. These assets are comprised of debt investments and cost and equity method investments of $ 345 million, goodwill of $ 14,710 million and other identifiable intangibles, net of $ 4,499 million. | text | 14710 | monetaryItemType | text: <entity> 14710 </entity> <entity type> monetaryItemType </entity type> <context> Certain assets are carried on the accompanying consolidated balance sheets at cost and are not remeasured to fair value on a recurring basis. As of December 31, 2024, assets carried on the balance sheet and not remeasured to fair value on a recurring basis totaled $ 19,554 million and were identified as Level 3. These assets are comprised of debt investments and cost and equity method investments of $ 345 million, goodwill of $ 14,710 million and other identifiable intangibles, net of $ 4,499 million. </context> | us-gaap:GoodwillFairValueDisclosure |
Certain assets are carried on the accompanying consolidated balance sheets at cost and are not remeasured to fair value on a recurring basis. As of December 31, 2024, assets carried on the balance sheet and not remeasured to fair value on a recurring basis totaled $ 19,554 million and were identified as Level 3. These assets are comprised of debt investments and cost and equity method investments of $ 345 million, goodwill of $ 14,710 million and other identifiable intangibles, net of $ 4,499 million. | text | 4499 | monetaryItemType | text: <entity> 4499 </entity> <entity type> monetaryItemType </entity type> <context> Certain assets are carried on the accompanying consolidated balance sheets at cost and are not remeasured to fair value on a recurring basis. As of December 31, 2024, assets carried on the balance sheet and not remeasured to fair value on a recurring basis totaled $ 19,554 million and were identified as Level 3. These assets are comprised of debt investments and cost and equity method investments of $ 345 million, goodwill of $ 14,710 million and other identifiable intangibles, net of $ 4,499 million. </context> | us-gaap:IntangibleAssetsNetExcludingGoodwill |
As of December 31, 2024, the Company has $ 4,499 million of other identifiable intangible assets. Amortization expense associated with other identifiable definite-lived intangible assets was as follows: | text | 4499 | monetaryItemType | text: <entity> 4499 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company has $ 4,499 million of other identifiable intangible assets. Amortization expense associated with other identifiable definite-lived intangible assets was as follows: </context> | us-gaap:IntangibleAssetsNetExcludingGoodwill |
Estimated amortization expense for existing other identifiable intangible assets is expected to be approximately $ 881 million, $ 738 million, $ 606 million, $ 485 million and $ 371 million for the years ending December 31, 2025, 2026, 2027, 2028 and 2029, respectively. Estimated amortization expense can be affected by various factors such as future acquisitions, divestitures, abandonments or impairments. | text | 881 | monetaryItemType | text: <entity> 881 </entity> <entity type> monetaryItemType </entity type> <context> Estimated amortization expense for existing other identifiable intangible assets is expected to be approximately $ 881 million, $ 738 million, $ 606 million, $ 485 million and $ 371 million for the years ending December 31, 2025, 2026, 2027, 2028 and 2029, respectively. Estimated amortization expense can be affected by various factors such as future acquisitions, divestitures, abandonments or impairments. </context> | us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths |
Estimated amortization expense for existing other identifiable intangible assets is expected to be approximately $ 881 million, $ 738 million, $ 606 million, $ 485 million and $ 371 million for the years ending December 31, 2025, 2026, 2027, 2028 and 2029, respectively. Estimated amortization expense can be affected by various factors such as future acquisitions, divestitures, abandonments or impairments. | text | 738 | monetaryItemType | text: <entity> 738 </entity> <entity type> monetaryItemType </entity type> <context> Estimated amortization expense for existing other identifiable intangible assets is expected to be approximately $ 881 million, $ 738 million, $ 606 million, $ 485 million and $ 371 million for the years ending December 31, 2025, 2026, 2027, 2028 and 2029, respectively. Estimated amortization expense can be affected by various factors such as future acquisitions, divestitures, abandonments or impairments. </context> | us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo |
Estimated amortization expense for existing other identifiable intangible assets is expected to be approximately $ 881 million, $ 738 million, $ 606 million, $ 485 million and $ 371 million for the years ending December 31, 2025, 2026, 2027, 2028 and 2029, respectively. Estimated amortization expense can be affected by various factors such as future acquisitions, divestitures, abandonments or impairments. | text | 606 | monetaryItemType | text: <entity> 606 </entity> <entity type> monetaryItemType </entity type> <context> Estimated amortization expense for existing other identifiable intangible assets is expected to be approximately $ 881 million, $ 738 million, $ 606 million, $ 485 million and $ 371 million for the years ending December 31, 2025, 2026, 2027, 2028 and 2029, respectively. Estimated amortization expense can be affected by various factors such as future acquisitions, divestitures, abandonments or impairments. </context> | us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearThree |
Estimated amortization expense for existing other identifiable intangible assets is expected to be approximately $ 881 million, $ 738 million, $ 606 million, $ 485 million and $ 371 million for the years ending December 31, 2025, 2026, 2027, 2028 and 2029, respectively. Estimated amortization expense can be affected by various factors such as future acquisitions, divestitures, abandonments or impairments. | text | 485 | monetaryItemType | text: <entity> 485 </entity> <entity type> monetaryItemType </entity type> <context> Estimated amortization expense for existing other identifiable intangible assets is expected to be approximately $ 881 million, $ 738 million, $ 606 million, $ 485 million and $ 371 million for the years ending December 31, 2025, 2026, 2027, 2028 and 2029, respectively. Estimated amortization expense can be affected by various factors such as future acquisitions, divestitures, abandonments or impairments. </context> | us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFour |
Estimated amortization expense for existing other identifiable intangible assets is expected to be approximately $ 881 million, $ 738 million, $ 606 million, $ 485 million and $ 371 million for the years ending December 31, 2025, 2026, 2027, 2028 and 2029, respectively. Estimated amortization expense can be affected by various factors such as future acquisitions, divestitures, abandonments or impairments. | text | 371 | monetaryItemType | text: <entity> 371 </entity> <entity type> monetaryItemType </entity type> <context> Estimated amortization expense for existing other identifiable intangible assets is expected to be approximately $ 881 million, $ 738 million, $ 606 million, $ 485 million and $ 371 million for the years ending December 31, 2025, 2026, 2027, 2028 and 2029, respectively. Estimated amortization expense can be affected by various factors such as future acquisitions, divestitures, abandonments or impairments. </context> | us-gaap:FiniteLivedIntangibleAssetsAmortizationExpenseYearFive |
As of December 31, 2024, the Fifth Amended and Restated Credit Agreement (the “Credit Agreement”) provided financing through several senior secured credit facilities of up to $ 6,585 million, which consisted of $ 5,415 million principal amounts of debt outstanding (as detailed in the table above), and $ 1,170 million of available borrowing capacity on the $ 2,000 million revolving credit facility and standby letters of credit. The revolving credit facility is comprised of a $ 1,175 million senior secured revolving facility available in U.S. dollars, a $ 600 million senior secured revolving facility available in U.S. dollars, Euros, Swiss Francs and other foreign currencies, and a $ 225 million senior secured revolving facility available in U.S. dollars and Yen. | text | 6585 | monetaryItemType | text: <entity> 6585 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Fifth Amended and Restated Credit Agreement (the “Credit Agreement”) provided financing through several senior secured credit facilities of up to $ 6,585 million, which consisted of $ 5,415 million principal amounts of debt outstanding (as detailed in the table above), and $ 1,170 million of available borrowing capacity on the $ 2,000 million revolving credit facility and standby letters of credit. The revolving credit facility is comprised of a $ 1,175 million senior secured revolving facility available in U.S. dollars, a $ 600 million senior secured revolving facility available in U.S. dollars, Euros, Swiss Francs and other foreign currencies, and a $ 225 million senior secured revolving facility available in U.S. dollars and Yen. </context> | us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity |
As of December 31, 2024, the Fifth Amended and Restated Credit Agreement (the “Credit Agreement”) provided financing through several senior secured credit facilities of up to $ 6,585 million, which consisted of $ 5,415 million principal amounts of debt outstanding (as detailed in the table above), and $ 1,170 million of available borrowing capacity on the $ 2,000 million revolving credit facility and standby letters of credit. The revolving credit facility is comprised of a $ 1,175 million senior secured revolving facility available in U.S. dollars, a $ 600 million senior secured revolving facility available in U.S. dollars, Euros, Swiss Francs and other foreign currencies, and a $ 225 million senior secured revolving facility available in U.S. dollars and Yen. | text | 5415 | monetaryItemType | text: <entity> 5415 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Fifth Amended and Restated Credit Agreement (the “Credit Agreement”) provided financing through several senior secured credit facilities of up to $ 6,585 million, which consisted of $ 5,415 million principal amounts of debt outstanding (as detailed in the table above), and $ 1,170 million of available borrowing capacity on the $ 2,000 million revolving credit facility and standby letters of credit. The revolving credit facility is comprised of a $ 1,175 million senior secured revolving facility available in U.S. dollars, a $ 600 million senior secured revolving facility available in U.S. dollars, Euros, Swiss Francs and other foreign currencies, and a $ 225 million senior secured revolving facility available in U.S. dollars and Yen. </context> | us-gaap:DebtInstrumentCarryingAmount |
As of December 31, 2024, the Fifth Amended and Restated Credit Agreement (the “Credit Agreement”) provided financing through several senior secured credit facilities of up to $ 6,585 million, which consisted of $ 5,415 million principal amounts of debt outstanding (as detailed in the table above), and $ 1,170 million of available borrowing capacity on the $ 2,000 million revolving credit facility and standby letters of credit. The revolving credit facility is comprised of a $ 1,175 million senior secured revolving facility available in U.S. dollars, a $ 600 million senior secured revolving facility available in U.S. dollars, Euros, Swiss Francs and other foreign currencies, and a $ 225 million senior secured revolving facility available in U.S. dollars and Yen. | text | 1170 | monetaryItemType | text: <entity> 1170 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Fifth Amended and Restated Credit Agreement (the “Credit Agreement”) provided financing through several senior secured credit facilities of up to $ 6,585 million, which consisted of $ 5,415 million principal amounts of debt outstanding (as detailed in the table above), and $ 1,170 million of available borrowing capacity on the $ 2,000 million revolving credit facility and standby letters of credit. The revolving credit facility is comprised of a $ 1,175 million senior secured revolving facility available in U.S. dollars, a $ 600 million senior secured revolving facility available in U.S. dollars, Euros, Swiss Francs and other foreign currencies, and a $ 225 million senior secured revolving facility available in U.S. dollars and Yen. </context> | us-gaap:LineOfCreditFacilityRemainingBorrowingCapacity |
As of December 31, 2024, the Fifth Amended and Restated Credit Agreement (the “Credit Agreement”) provided financing through several senior secured credit facilities of up to $ 6,585 million, which consisted of $ 5,415 million principal amounts of debt outstanding (as detailed in the table above), and $ 1,170 million of available borrowing capacity on the $ 2,000 million revolving credit facility and standby letters of credit. The revolving credit facility is comprised of a $ 1,175 million senior secured revolving facility available in U.S. dollars, a $ 600 million senior secured revolving facility available in U.S. dollars, Euros, Swiss Francs and other foreign currencies, and a $ 225 million senior secured revolving facility available in U.S. dollars and Yen. | text | 2000 | monetaryItemType | text: <entity> 2000 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Fifth Amended and Restated Credit Agreement (the “Credit Agreement”) provided financing through several senior secured credit facilities of up to $ 6,585 million, which consisted of $ 5,415 million principal amounts of debt outstanding (as detailed in the table above), and $ 1,170 million of available borrowing capacity on the $ 2,000 million revolving credit facility and standby letters of credit. The revolving credit facility is comprised of a $ 1,175 million senior secured revolving facility available in U.S. dollars, a $ 600 million senior secured revolving facility available in U.S. dollars, Euros, Swiss Francs and other foreign currencies, and a $ 225 million senior secured revolving facility available in U.S. dollars and Yen. </context> | us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity |
As of December 31, 2024, the Fifth Amended and Restated Credit Agreement (the “Credit Agreement”) provided financing through several senior secured credit facilities of up to $ 6,585 million, which consisted of $ 5,415 million principal amounts of debt outstanding (as detailed in the table above), and $ 1,170 million of available borrowing capacity on the $ 2,000 million revolving credit facility and standby letters of credit. The revolving credit facility is comprised of a $ 1,175 million senior secured revolving facility available in U.S. dollars, a $ 600 million senior secured revolving facility available in U.S. dollars, Euros, Swiss Francs and other foreign currencies, and a $ 225 million senior secured revolving facility available in U.S. dollars and Yen. | text | 1175 | monetaryItemType | text: <entity> 1175 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Fifth Amended and Restated Credit Agreement (the “Credit Agreement”) provided financing through several senior secured credit facilities of up to $ 6,585 million, which consisted of $ 5,415 million principal amounts of debt outstanding (as detailed in the table above), and $ 1,170 million of available borrowing capacity on the $ 2,000 million revolving credit facility and standby letters of credit. The revolving credit facility is comprised of a $ 1,175 million senior secured revolving facility available in U.S. dollars, a $ 600 million senior secured revolving facility available in U.S. dollars, Euros, Swiss Francs and other foreign currencies, and a $ 225 million senior secured revolving facility available in U.S. dollars and Yen. </context> | us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity |
As of December 31, 2024, the Fifth Amended and Restated Credit Agreement (the “Credit Agreement”) provided financing through several senior secured credit facilities of up to $ 6,585 million, which consisted of $ 5,415 million principal amounts of debt outstanding (as detailed in the table above), and $ 1,170 million of available borrowing capacity on the $ 2,000 million revolving credit facility and standby letters of credit. The revolving credit facility is comprised of a $ 1,175 million senior secured revolving facility available in U.S. dollars, a $ 600 million senior secured revolving facility available in U.S. dollars, Euros, Swiss Francs and other foreign currencies, and a $ 225 million senior secured revolving facility available in U.S. dollars and Yen. | text | 600 | monetaryItemType | text: <entity> 600 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Fifth Amended and Restated Credit Agreement (the “Credit Agreement”) provided financing through several senior secured credit facilities of up to $ 6,585 million, which consisted of $ 5,415 million principal amounts of debt outstanding (as detailed in the table above), and $ 1,170 million of available borrowing capacity on the $ 2,000 million revolving credit facility and standby letters of credit. The revolving credit facility is comprised of a $ 1,175 million senior secured revolving facility available in U.S. dollars, a $ 600 million senior secured revolving facility available in U.S. dollars, Euros, Swiss Francs and other foreign currencies, and a $ 225 million senior secured revolving facility available in U.S. dollars and Yen. </context> | us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity |
As of December 31, 2024, the Fifth Amended and Restated Credit Agreement (the “Credit Agreement”) provided financing through several senior secured credit facilities of up to $ 6,585 million, which consisted of $ 5,415 million principal amounts of debt outstanding (as detailed in the table above), and $ 1,170 million of available borrowing capacity on the $ 2,000 million revolving credit facility and standby letters of credit. The revolving credit facility is comprised of a $ 1,175 million senior secured revolving facility available in U.S. dollars, a $ 600 million senior secured revolving facility available in U.S. dollars, Euros, Swiss Francs and other foreign currencies, and a $ 225 million senior secured revolving facility available in U.S. dollars and Yen. | text | 225 | monetaryItemType | text: <entity> 225 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Fifth Amended and Restated Credit Agreement (the “Credit Agreement”) provided financing through several senior secured credit facilities of up to $ 6,585 million, which consisted of $ 5,415 million principal amounts of debt outstanding (as detailed in the table above), and $ 1,170 million of available borrowing capacity on the $ 2,000 million revolving credit facility and standby letters of credit. The revolving credit facility is comprised of a $ 1,175 million senior secured revolving facility available in U.S. dollars, a $ 600 million senior secured revolving facility available in U.S. dollars, Euros, Swiss Francs and other foreign currencies, and a $ 225 million senior secured revolving facility available in U.S. dollars and Yen. </context> | us-gaap:LineOfCreditFacilityCurrentBorrowingCapacity |
On November 28, 2023, the Company entered into an amendment (the “Amendment”) to its Credit Agreement, among IQVIA Inc., a wholly owned subsidiary of the Company, the Company, IQVIA RDS Inc., a wholly owned subsidiary of the Company, the other guarantors party thereto, Bank of America, N.A. as administrative agent and as collateral agent, and the Lenders (as defined therein) party thereto. Pursuant to the Amendment, the Company borrowed $ 1,500 million in incremental Term B-4 Dollar Loans (as defined in the Credit Agreement) due January 2, 2031. The net proceeds from the Term B-4 Dollar Loans were used to repay certain of the outstanding term loans due in 2024 and in 2025 under the Company’s senior secured credit facilities, and to pay fees and expenses related to the Amendment and the offering of 2029 Senior Secured Notes (as defined below). In connection with this Amendment, the Company recognized a $ 6 million loss on extinguishment of debt, which includes fees and expenses. | text | 1500 | monetaryItemType | text: <entity> 1500 </entity> <entity type> monetaryItemType </entity type> <context> On November 28, 2023, the Company entered into an amendment (the “Amendment”) to its Credit Agreement, among IQVIA Inc., a wholly owned subsidiary of the Company, the Company, IQVIA RDS Inc., a wholly owned subsidiary of the Company, the other guarantors party thereto, Bank of America, N.A. as administrative agent and as collateral agent, and the Lenders (as defined therein) party thereto. Pursuant to the Amendment, the Company borrowed $ 1,500 million in incremental Term B-4 Dollar Loans (as defined in the Credit Agreement) due January 2, 2031. The net proceeds from the Term B-4 Dollar Loans were used to repay certain of the outstanding term loans due in 2024 and in 2025 under the Company’s senior secured credit facilities, and to pay fees and expenses related to the Amendment and the offering of 2029 Senior Secured Notes (as defined below). In connection with this Amendment, the Company recognized a $ 6 million loss on extinguishment of debt, which includes fees and expenses. </context> | us-gaap:DebtInstrumentCarryingAmount |
On November 28, 2023, the Company entered into an amendment (the “Amendment”) to its Credit Agreement, among IQVIA Inc., a wholly owned subsidiary of the Company, the Company, IQVIA RDS Inc., a wholly owned subsidiary of the Company, the other guarantors party thereto, Bank of America, N.A. as administrative agent and as collateral agent, and the Lenders (as defined therein) party thereto. Pursuant to the Amendment, the Company borrowed $ 1,500 million in incremental Term B-4 Dollar Loans (as defined in the Credit Agreement) due January 2, 2031. The net proceeds from the Term B-4 Dollar Loans were used to repay certain of the outstanding term loans due in 2024 and in 2025 under the Company’s senior secured credit facilities, and to pay fees and expenses related to the Amendment and the offering of 2029 Senior Secured Notes (as defined below). In connection with this Amendment, the Company recognized a $ 6 million loss on extinguishment of debt, which includes fees and expenses. | text | 6 | monetaryItemType | text: <entity> 6 </entity> <entity type> monetaryItemType </entity type> <context> On November 28, 2023, the Company entered into an amendment (the “Amendment”) to its Credit Agreement, among IQVIA Inc., a wholly owned subsidiary of the Company, the Company, IQVIA RDS Inc., a wholly owned subsidiary of the Company, the other guarantors party thereto, Bank of America, N.A. as administrative agent and as collateral agent, and the Lenders (as defined therein) party thereto. Pursuant to the Amendment, the Company borrowed $ 1,500 million in incremental Term B-4 Dollar Loans (as defined in the Credit Agreement) due January 2, 2031. The net proceeds from the Term B-4 Dollar Loans were used to repay certain of the outstanding term loans due in 2024 and in 2025 under the Company’s senior secured credit facilities, and to pay fees and expenses related to the Amendment and the offering of 2029 Senior Secured Notes (as defined below). In connection with this Amendment, the Company recognized a $ 6 million loss on extinguishment of debt, which includes fees and expenses. </context> | us-gaap:GainsLossesOnExtinguishmentOfDebt |
On April 17, 2023, the Company increased the capacity of the senior secured revolving credit facility by $ 500 million U.S. dollars, bringing the total capacity of the revolving credit facility to $ 2,000 million. At the same time, the Company also amended the benchmark rate of the U.S dollar revolving credit facility and the U.S dollar Term A Loans from U.S dollar LIBOR to U.S. dollar Secured Overnight Financing Rate term rates ("Term SOFR"), plus a 10 basis point Credit Spread Adjustment. | text | 500 | monetaryItemType | text: <entity> 500 </entity> <entity type> monetaryItemType </entity type> <context> On April 17, 2023, the Company increased the capacity of the senior secured revolving credit facility by $ 500 million U.S. dollars, bringing the total capacity of the revolving credit facility to $ 2,000 million. At the same time, the Company also amended the benchmark rate of the U.S dollar revolving credit facility and the U.S dollar Term A Loans from U.S dollar LIBOR to U.S. dollar Secured Overnight Financing Rate term rates ("Term SOFR"), plus a 10 basis point Credit Spread Adjustment. </context> | us-gaap:DebtInstrumentCarryingAmount |
On April 17, 2023, the Company increased the capacity of the senior secured revolving credit facility by $ 500 million U.S. dollars, bringing the total capacity of the revolving credit facility to $ 2,000 million. At the same time, the Company also amended the benchmark rate of the U.S dollar revolving credit facility and the U.S dollar Term A Loans from U.S dollar LIBOR to U.S. dollar Secured Overnight Financing Rate term rates ("Term SOFR"), plus a 10 basis point Credit Spread Adjustment. | text | 2000 | monetaryItemType | text: <entity> 2000 </entity> <entity type> monetaryItemType </entity type> <context> On April 17, 2023, the Company increased the capacity of the senior secured revolving credit facility by $ 500 million U.S. dollars, bringing the total capacity of the revolving credit facility to $ 2,000 million. At the same time, the Company also amended the benchmark rate of the U.S dollar revolving credit facility and the U.S dollar Term A Loans from U.S dollar LIBOR to U.S. dollar Secured Overnight Financing Rate term rates ("Term SOFR"), plus a 10 basis point Credit Spread Adjustment. </context> | us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity |
On April 17, 2023, the Company increased the capacity of the senior secured revolving credit facility by $ 500 million U.S. dollars, bringing the total capacity of the revolving credit facility to $ 2,000 million. At the same time, the Company also amended the benchmark rate of the U.S dollar revolving credit facility and the U.S dollar Term A Loans from U.S dollar LIBOR to U.S. dollar Secured Overnight Financing Rate term rates ("Term SOFR"), plus a 10 basis point Credit Spread Adjustment. | text | 10 | percentItemType | text: <entity> 10 </entity> <entity type> percentItemType </entity type> <context> On April 17, 2023, the Company increased the capacity of the senior secured revolving credit facility by $ 500 million U.S. dollars, bringing the total capacity of the revolving credit facility to $ 2,000 million. At the same time, the Company also amended the benchmark rate of the U.S dollar revolving credit facility and the U.S dollar Term A Loans from U.S dollar LIBOR to U.S. dollar Secured Overnight Financing Rate term rates ("Term SOFR"), plus a 10 basis point Credit Spread Adjustment. </context> | us-gaap:DebtInstrumentBasisSpreadOnVariableRate1 |
On November 28, 2023, IQVIA Inc. (the “Issuer”), completed the issuance and sale of $ 1,250 million in gross proceeds of 6.250 % senior secured notes due 2029 (the “2029 Senior Secured Notes”). The 2029 Senior Secured Notes were issued pursuant to an Indenture, dated November 28, 2023, among the Issuer, U.S. Bank Trust Company, National Association, as trustee of the 2029 Senior Secured Notes and as collateral agent, and the Company and certain subsidiaries of the Issuer as guarantors. The net proceeds from the 2029 Senior Secured Notes offering were used to repay certain of the outstanding term loans under the Company’s senior secured credit facilities due in 2024 and in 2025, and to pay fees and expenses related to the 2029 Senior Secured Notes offering and the Amendment. | text | 1250 | monetaryItemType | text: <entity> 1250 </entity> <entity type> monetaryItemType </entity type> <context> On November 28, 2023, IQVIA Inc. (the “Issuer”), completed the issuance and sale of $ 1,250 million in gross proceeds of 6.250 % senior secured notes due 2029 (the “2029 Senior Secured Notes”). The 2029 Senior Secured Notes were issued pursuant to an Indenture, dated November 28, 2023, among the Issuer, U.S. Bank Trust Company, National Association, as trustee of the 2029 Senior Secured Notes and as collateral agent, and the Company and certain subsidiaries of the Issuer as guarantors. The net proceeds from the 2029 Senior Secured Notes offering were used to repay certain of the outstanding term loans under the Company’s senior secured credit facilities due in 2024 and in 2025, and to pay fees and expenses related to the 2029 Senior Secured Notes offering and the Amendment. </context> | us-gaap:DebtInstrumentCarryingAmount |
On November 28, 2023, IQVIA Inc. (the “Issuer”), completed the issuance and sale of $ 1,250 million in gross proceeds of 6.250 % senior secured notes due 2029 (the “2029 Senior Secured Notes”). The 2029 Senior Secured Notes were issued pursuant to an Indenture, dated November 28, 2023, among the Issuer, U.S. Bank Trust Company, National Association, as trustee of the 2029 Senior Secured Notes and as collateral agent, and the Company and certain subsidiaries of the Issuer as guarantors. The net proceeds from the 2029 Senior Secured Notes offering were used to repay certain of the outstanding term loans under the Company’s senior secured credit facilities due in 2024 and in 2025, and to pay fees and expenses related to the 2029 Senior Secured Notes offering and the Amendment. | text | 6.250 | percentItemType | text: <entity> 6.250 </entity> <entity type> percentItemType </entity type> <context> On November 28, 2023, IQVIA Inc. (the “Issuer”), completed the issuance and sale of $ 1,250 million in gross proceeds of 6.250 % senior secured notes due 2029 (the “2029 Senior Secured Notes”). The 2029 Senior Secured Notes were issued pursuant to an Indenture, dated November 28, 2023, among the Issuer, U.S. Bank Trust Company, National Association, as trustee of the 2029 Senior Secured Notes and as collateral agent, and the Company and certain subsidiaries of the Issuer as guarantors. The net proceeds from the 2029 Senior Secured Notes offering were used to repay certain of the outstanding term loans under the Company’s senior secured credit facilities due in 2024 and in 2025, and to pay fees and expenses related to the 2029 Senior Secured Notes offering and the Amendment. </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
The 2029 Senior Secured Notes are secured obligations of the Company, will mature on February 1, 2029, unless earlier repurchased or redeemed in accordance with their terms, and bear interest at the rate of 6.250 % per year, with interest payable semi-annually on February 1 and August 1 of each year, beginning on February 1, 2024. The Company may redeem the 2029 Senior Secured Notes prior to January 1, 2029 subject to a customary make-whole premium, and thereafter subject to a redemption price equal to 100% of the principal amount thereof plus accrued and unpaid interest. | text | 6.250 | percentItemType | text: <entity> 6.250 </entity> <entity type> percentItemType </entity type> <context> The 2029 Senior Secured Notes are secured obligations of the Company, will mature on February 1, 2029, unless earlier repurchased or redeemed in accordance with their terms, and bear interest at the rate of 6.250 % per year, with interest payable semi-annually on February 1 and August 1 of each year, beginning on February 1, 2024. The Company may redeem the 2029 Senior Secured Notes prior to January 1, 2029 subject to a customary make-whole premium, and thereafter subject to a redemption price equal to 100% of the principal amount thereof plus accrued and unpaid interest. </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
On May 23, 2023, IQVIA Inc. (the “Issuer”) completed the issuance and sale of $ 750 million in gross proceeds of 5.700 % senior secured notes due 2028 (the “2028 Senior Secured Notes”). The 2028 Senior Secured Notes were issued pursuant to an Indenture, dated May 23, 2023, among the Issuer, U.S. Bank Trust Company, National Association, as trustee of the 2028 Senior Secured Notes and as collateral agent, and the Company and certain subsidiaries of the Issuer as guarantors. The net proceeds from the 2028 Senior Secured Notes offering were used to repay existing borrowings under the Company’s revolving credit facility and to pay fees and expenses related to the 2028 Senior Secured Notes offering and offering of 2030 Senior Notes (as defined below). | text | 750 | monetaryItemType | text: <entity> 750 </entity> <entity type> monetaryItemType </entity type> <context> On May 23, 2023, IQVIA Inc. (the “Issuer”) completed the issuance and sale of $ 750 million in gross proceeds of 5.700 % senior secured notes due 2028 (the “2028 Senior Secured Notes”). The 2028 Senior Secured Notes were issued pursuant to an Indenture, dated May 23, 2023, among the Issuer, U.S. Bank Trust Company, National Association, as trustee of the 2028 Senior Secured Notes and as collateral agent, and the Company and certain subsidiaries of the Issuer as guarantors. The net proceeds from the 2028 Senior Secured Notes offering were used to repay existing borrowings under the Company’s revolving credit facility and to pay fees and expenses related to the 2028 Senior Secured Notes offering and offering of 2030 Senior Notes (as defined below). </context> | us-gaap:DebtInstrumentCarryingAmount |
On May 23, 2023, IQVIA Inc. (the “Issuer”) completed the issuance and sale of $ 750 million in gross proceeds of 5.700 % senior secured notes due 2028 (the “2028 Senior Secured Notes”). The 2028 Senior Secured Notes were issued pursuant to an Indenture, dated May 23, 2023, among the Issuer, U.S. Bank Trust Company, National Association, as trustee of the 2028 Senior Secured Notes and as collateral agent, and the Company and certain subsidiaries of the Issuer as guarantors. The net proceeds from the 2028 Senior Secured Notes offering were used to repay existing borrowings under the Company’s revolving credit facility and to pay fees and expenses related to the 2028 Senior Secured Notes offering and offering of 2030 Senior Notes (as defined below). | text | 5.700 | percentItemType | text: <entity> 5.700 </entity> <entity type> percentItemType </entity type> <context> On May 23, 2023, IQVIA Inc. (the “Issuer”) completed the issuance and sale of $ 750 million in gross proceeds of 5.700 % senior secured notes due 2028 (the “2028 Senior Secured Notes”). The 2028 Senior Secured Notes were issued pursuant to an Indenture, dated May 23, 2023, among the Issuer, U.S. Bank Trust Company, National Association, as trustee of the 2028 Senior Secured Notes and as collateral agent, and the Company and certain subsidiaries of the Issuer as guarantors. The net proceeds from the 2028 Senior Secured Notes offering were used to repay existing borrowings under the Company’s revolving credit facility and to pay fees and expenses related to the 2028 Senior Secured Notes offering and offering of 2030 Senior Notes (as defined below). </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
The 2028 Senior Secured Notes are secured obligations of the Company, will mature on May 15, 2028, unless earlier repurchased or redeemed in accordance with their terms, and bear interest at the rate of 5.700 % per year, with interest payable semi-annually on May 15 and November 15 of each year, beginning on November 15, 2023. The Company may redeem the 2028 Senior Secured Notes prior to April 15, 2028 subject to a customary make-whole premium, and thereafter subject to a redemption price equal to 100% of the principal amount thereof plus accrued and unpaid interest. | text | 5.700 | percentItemType | text: <entity> 5.700 </entity> <entity type> percentItemType </entity type> <context> The 2028 Senior Secured Notes are secured obligations of the Company, will mature on May 15, 2028, unless earlier repurchased or redeemed in accordance with their terms, and bear interest at the rate of 5.700 % per year, with interest payable semi-annually on May 15 and November 15 of each year, beginning on November 15, 2023. The Company may redeem the 2028 Senior Secured Notes prior to April 15, 2028 subject to a customary make-whole premium, and thereafter subject to a redemption price equal to 100% of the principal amount thereof plus accrued and unpaid interest. </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
In February 2024, the Issuer completed an exchange offer in which it issued $ 1,250 million aggregate principal amount of 6.250 % Senior Secured Notes due 2029 registered under the Securities Act (the “2029 Registered Notes”) and $ 750 million aggregate principal amount of 5.700 % Senior Secured Notes due 2028 registered under the Securities Act (the “2028 Registered Notes” and, together with the 2029 Registered Notes, the 2029 Senior Secured Notes, and the 2028 Senior Secured Notes, the “Notes”) in exchange for the same principal amount and substantially identical terms of the 2029 Senior Secured Notes and 2028 Senior Secured Notes, respectively. | text | 1250 | monetaryItemType | text: <entity> 1250 </entity> <entity type> monetaryItemType </entity type> <context> In February 2024, the Issuer completed an exchange offer in which it issued $ 1,250 million aggregate principal amount of 6.250 % Senior Secured Notes due 2029 registered under the Securities Act (the “2029 Registered Notes”) and $ 750 million aggregate principal amount of 5.700 % Senior Secured Notes due 2028 registered under the Securities Act (the “2028 Registered Notes” and, together with the 2029 Registered Notes, the 2029 Senior Secured Notes, and the 2028 Senior Secured Notes, the “Notes”) in exchange for the same principal amount and substantially identical terms of the 2029 Senior Secured Notes and 2028 Senior Secured Notes, respectively. </context> | us-gaap:DebtInstrumentCarryingAmount |
In February 2024, the Issuer completed an exchange offer in which it issued $ 1,250 million aggregate principal amount of 6.250 % Senior Secured Notes due 2029 registered under the Securities Act (the “2029 Registered Notes”) and $ 750 million aggregate principal amount of 5.700 % Senior Secured Notes due 2028 registered under the Securities Act (the “2028 Registered Notes” and, together with the 2029 Registered Notes, the 2029 Senior Secured Notes, and the 2028 Senior Secured Notes, the “Notes”) in exchange for the same principal amount and substantially identical terms of the 2029 Senior Secured Notes and 2028 Senior Secured Notes, respectively. | text | 6.250 | percentItemType | text: <entity> 6.250 </entity> <entity type> percentItemType </entity type> <context> In February 2024, the Issuer completed an exchange offer in which it issued $ 1,250 million aggregate principal amount of 6.250 % Senior Secured Notes due 2029 registered under the Securities Act (the “2029 Registered Notes”) and $ 750 million aggregate principal amount of 5.700 % Senior Secured Notes due 2028 registered under the Securities Act (the “2028 Registered Notes” and, together with the 2029 Registered Notes, the 2029 Senior Secured Notes, and the 2028 Senior Secured Notes, the “Notes”) in exchange for the same principal amount and substantially identical terms of the 2029 Senior Secured Notes and 2028 Senior Secured Notes, respectively. </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
In February 2024, the Issuer completed an exchange offer in which it issued $ 1,250 million aggregate principal amount of 6.250 % Senior Secured Notes due 2029 registered under the Securities Act (the “2029 Registered Notes”) and $ 750 million aggregate principal amount of 5.700 % Senior Secured Notes due 2028 registered under the Securities Act (the “2028 Registered Notes” and, together with the 2029 Registered Notes, the 2029 Senior Secured Notes, and the 2028 Senior Secured Notes, the “Notes”) in exchange for the same principal amount and substantially identical terms of the 2029 Senior Secured Notes and 2028 Senior Secured Notes, respectively. | text | 750 | monetaryItemType | text: <entity> 750 </entity> <entity type> monetaryItemType </entity type> <context> In February 2024, the Issuer completed an exchange offer in which it issued $ 1,250 million aggregate principal amount of 6.250 % Senior Secured Notes due 2029 registered under the Securities Act (the “2029 Registered Notes”) and $ 750 million aggregate principal amount of 5.700 % Senior Secured Notes due 2028 registered under the Securities Act (the “2028 Registered Notes” and, together with the 2029 Registered Notes, the 2029 Senior Secured Notes, and the 2028 Senior Secured Notes, the “Notes”) in exchange for the same principal amount and substantially identical terms of the 2029 Senior Secured Notes and 2028 Senior Secured Notes, respectively. </context> | us-gaap:DebtInstrumentCarryingAmount |
In February 2024, the Issuer completed an exchange offer in which it issued $ 1,250 million aggregate principal amount of 6.250 % Senior Secured Notes due 2029 registered under the Securities Act (the “2029 Registered Notes”) and $ 750 million aggregate principal amount of 5.700 % Senior Secured Notes due 2028 registered under the Securities Act (the “2028 Registered Notes” and, together with the 2029 Registered Notes, the 2029 Senior Secured Notes, and the 2028 Senior Secured Notes, the “Notes”) in exchange for the same principal amount and substantially identical terms of the 2029 Senior Secured Notes and 2028 Senior Secured Notes, respectively. | text | 5.700 | percentItemType | text: <entity> 5.700 </entity> <entity type> percentItemType </entity type> <context> In February 2024, the Issuer completed an exchange offer in which it issued $ 1,250 million aggregate principal amount of 6.250 % Senior Secured Notes due 2029 registered under the Securities Act (the “2029 Registered Notes”) and $ 750 million aggregate principal amount of 5.700 % Senior Secured Notes due 2028 registered under the Securities Act (the “2028 Registered Notes” and, together with the 2029 Registered Notes, the 2029 Senior Secured Notes, and the 2028 Senior Secured Notes, the “Notes”) in exchange for the same principal amount and substantially identical terms of the 2029 Senior Secured Notes and 2028 Senior Secured Notes, respectively. </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
On May 23, 2023, IQVIA Inc. (the “Issuer”) completed the issuance and sale of $ 500 million in gross proceeds of 6.500 % senior notes due 2030 (the “2030 Senior Notes”). The 2030 Senior Notes were issued pursuant to an Indenture, dated May 23, 2023, among the Issuer, U.S. Bank Trust Company, National Association, as trustee of the 2030 Senior Notes, and certain subsidiaries of the Issuer as guarantors. The net proceeds from the 2030 Senior Notes offering were used to repay existing borrowings under the Company’s revolving credit facility, and to pay fees and expenses related to the 2030 Senior Notes offering and 2028 Senior Secured Notes offering. | text | 500 | monetaryItemType | text: <entity> 500 </entity> <entity type> monetaryItemType </entity type> <context> On May 23, 2023, IQVIA Inc. (the “Issuer”) completed the issuance and sale of $ 500 million in gross proceeds of 6.500 % senior notes due 2030 (the “2030 Senior Notes”). The 2030 Senior Notes were issued pursuant to an Indenture, dated May 23, 2023, among the Issuer, U.S. Bank Trust Company, National Association, as trustee of the 2030 Senior Notes, and certain subsidiaries of the Issuer as guarantors. The net proceeds from the 2030 Senior Notes offering were used to repay existing borrowings under the Company’s revolving credit facility, and to pay fees and expenses related to the 2030 Senior Notes offering and 2028 Senior Secured Notes offering. </context> | us-gaap:DebtInstrumentCarryingAmount |
On May 23, 2023, IQVIA Inc. (the “Issuer”) completed the issuance and sale of $ 500 million in gross proceeds of 6.500 % senior notes due 2030 (the “2030 Senior Notes”). The 2030 Senior Notes were issued pursuant to an Indenture, dated May 23, 2023, among the Issuer, U.S. Bank Trust Company, National Association, as trustee of the 2030 Senior Notes, and certain subsidiaries of the Issuer as guarantors. The net proceeds from the 2030 Senior Notes offering were used to repay existing borrowings under the Company’s revolving credit facility, and to pay fees and expenses related to the 2030 Senior Notes offering and 2028 Senior Secured Notes offering. | text | 6.500 | percentItemType | text: <entity> 6.500 </entity> <entity type> percentItemType </entity type> <context> On May 23, 2023, IQVIA Inc. (the “Issuer”) completed the issuance and sale of $ 500 million in gross proceeds of 6.500 % senior notes due 2030 (the “2030 Senior Notes”). The 2030 Senior Notes were issued pursuant to an Indenture, dated May 23, 2023, among the Issuer, U.S. Bank Trust Company, National Association, as trustee of the 2030 Senior Notes, and certain subsidiaries of the Issuer as guarantors. The net proceeds from the 2030 Senior Notes offering were used to repay existing borrowings under the Company’s revolving credit facility, and to pay fees and expenses related to the 2030 Senior Notes offering and 2028 Senior Secured Notes offering. </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
The 2030 Senior Notes are unsecured obligations of the Company, will mature on May 15, 2030, unless earlier repurchased or redeemed in accordance with their terms, and bear interest at the rate of 6.500 % per year, with interest payable semi-annually on May 15 and November 15 of each year, beginning on November 15, 2023. The Company may redeem the 2030 Senior Notes prior to their final stated maturity, subject to a customary make-whole premium, at any time prior to May 15, 2026 (subject to a customary “equity claw” redemption right) and thereafter subject to a redemption premium declining from 3.250 % to 0.000 %. | text | 6.500 | percentItemType | text: <entity> 6.500 </entity> <entity type> percentItemType </entity type> <context> The 2030 Senior Notes are unsecured obligations of the Company, will mature on May 15, 2030, unless earlier repurchased or redeemed in accordance with their terms, and bear interest at the rate of 6.500 % per year, with interest payable semi-annually on May 15 and November 15 of each year, beginning on November 15, 2023. The Company may redeem the 2030 Senior Notes prior to their final stated maturity, subject to a customary make-whole premium, at any time prior to May 15, 2026 (subject to a customary “equity claw” redemption right) and thereafter subject to a redemption premium declining from 3.250 % to 0.000 %. </context> | us-gaap:DebtInstrumentInterestRateStatedPercentage |
The 2030 Senior Notes are unsecured obligations of the Company, will mature on May 15, 2030, unless earlier repurchased or redeemed in accordance with their terms, and bear interest at the rate of 6.500 % per year, with interest payable semi-annually on May 15 and November 15 of each year, beginning on November 15, 2023. The Company may redeem the 2030 Senior Notes prior to their final stated maturity, subject to a customary make-whole premium, at any time prior to May 15, 2026 (subject to a customary “equity claw” redemption right) and thereafter subject to a redemption premium declining from 3.250 % to 0.000 %. | text | 3.250 | percentItemType | text: <entity> 3.250 </entity> <entity type> percentItemType </entity type> <context> The 2030 Senior Notes are unsecured obligations of the Company, will mature on May 15, 2030, unless earlier repurchased or redeemed in accordance with their terms, and bear interest at the rate of 6.500 % per year, with interest payable semi-annually on May 15 and November 15 of each year, beginning on November 15, 2023. The Company may redeem the 2030 Senior Notes prior to their final stated maturity, subject to a customary make-whole premium, at any time prior to May 15, 2026 (subject to a customary “equity claw” redemption right) and thereafter subject to a redemption premium declining from 3.250 % to 0.000 %. </context> | us-gaap:DebtInstrumentRedemptionPricePercentage |
The 2030 Senior Notes are unsecured obligations of the Company, will mature on May 15, 2030, unless earlier repurchased or redeemed in accordance with their terms, and bear interest at the rate of 6.500 % per year, with interest payable semi-annually on May 15 and November 15 of each year, beginning on November 15, 2023. The Company may redeem the 2030 Senior Notes prior to their final stated maturity, subject to a customary make-whole premium, at any time prior to May 15, 2026 (subject to a customary “equity claw” redemption right) and thereafter subject to a redemption premium declining from 3.250 % to 0.000 %. | text | 0.000 | percentItemType | text: <entity> 0.000 </entity> <entity type> percentItemType </entity type> <context> The 2030 Senior Notes are unsecured obligations of the Company, will mature on May 15, 2030, unless earlier repurchased or redeemed in accordance with their terms, and bear interest at the rate of 6.500 % per year, with interest payable semi-annually on May 15 and November 15 of each year, beginning on November 15, 2023. The Company may redeem the 2030 Senior Notes prior to their final stated maturity, subject to a customary make-whole premium, at any time prior to May 15, 2026 (subject to a customary “equity claw” redemption right) and thereafter subject to a redemption premium declining from 3.250 % to 0.000 %. </context> | us-gaap:DebtInstrumentRedemptionPricePercentage |
On October 1, 2024, the Company amended its receivables financing facility to extend the term of the $ 550 million facility to October 1, 2027. Under the receivables financing facility, certain of the Company's accounts receivable are sold on a non-recourse basis by certain of the Company's consolidated subsidiaries (each, an “Originator”) to another of the Company's consolidated subsidiaries, a bankruptcy-remote special purpose entity (the “SPE”). The SPE obtained a term loan and revolving loan commitment from a third-party lender, secured by liens on the assets of the SPE, to finance the purchase of the accounts receivable, which includes a $ 440 million term loan and a $ 110 million revolving loan commitment. As of December 31, 2024, no additional amounts of revolving loans were available under the receivables financing facility. The Company has guaranteed the performance of the obligations of existing and future subsidiaries that sell and service the accounts receivable under the receivables financing facility. The assets of the SPE are not available to satisfy any of the Company’s obligations or any obligations of its subsidiaries. As of December 31, 2024, approximately $ 1,609 million of the Company's trade accounts receivable and unbilled services were pledged as collateral to secure the facility. | text | 550 | monetaryItemType | text: <entity> 550 </entity> <entity type> monetaryItemType </entity type> <context> On October 1, 2024, the Company amended its receivables financing facility to extend the term of the $ 550 million facility to October 1, 2027. Under the receivables financing facility, certain of the Company's accounts receivable are sold on a non-recourse basis by certain of the Company's consolidated subsidiaries (each, an “Originator”) to another of the Company's consolidated subsidiaries, a bankruptcy-remote special purpose entity (the “SPE”). The SPE obtained a term loan and revolving loan commitment from a third-party lender, secured by liens on the assets of the SPE, to finance the purchase of the accounts receivable, which includes a $ 440 million term loan and a $ 110 million revolving loan commitment. As of December 31, 2024, no additional amounts of revolving loans were available under the receivables financing facility. The Company has guaranteed the performance of the obligations of existing and future subsidiaries that sell and service the accounts receivable under the receivables financing facility. The assets of the SPE are not available to satisfy any of the Company’s obligations or any obligations of its subsidiaries. As of December 31, 2024, approximately $ 1,609 million of the Company's trade accounts receivable and unbilled services were pledged as collateral to secure the facility. </context> | us-gaap:LineOfCreditFacilityMaximumBorrowingCapacity |
On October 1, 2024, the Company amended its receivables financing facility to extend the term of the $ 550 million facility to October 1, 2027. Under the receivables financing facility, certain of the Company's accounts receivable are sold on a non-recourse basis by certain of the Company's consolidated subsidiaries (each, an “Originator”) to another of the Company's consolidated subsidiaries, a bankruptcy-remote special purpose entity (the “SPE”). The SPE obtained a term loan and revolving loan commitment from a third-party lender, secured by liens on the assets of the SPE, to finance the purchase of the accounts receivable, which includes a $ 440 million term loan and a $ 110 million revolving loan commitment. As of December 31, 2024, no additional amounts of revolving loans were available under the receivables financing facility. The Company has guaranteed the performance of the obligations of existing and future subsidiaries that sell and service the accounts receivable under the receivables financing facility. The assets of the SPE are not available to satisfy any of the Company’s obligations or any obligations of its subsidiaries. As of December 31, 2024, approximately $ 1,609 million of the Company's trade accounts receivable and unbilled services were pledged as collateral to secure the facility. | text | 440 | monetaryItemType | text: <entity> 440 </entity> <entity type> monetaryItemType </entity type> <context> On October 1, 2024, the Company amended its receivables financing facility to extend the term of the $ 550 million facility to October 1, 2027. Under the receivables financing facility, certain of the Company's accounts receivable are sold on a non-recourse basis by certain of the Company's consolidated subsidiaries (each, an “Originator”) to another of the Company's consolidated subsidiaries, a bankruptcy-remote special purpose entity (the “SPE”). The SPE obtained a term loan and revolving loan commitment from a third-party lender, secured by liens on the assets of the SPE, to finance the purchase of the accounts receivable, which includes a $ 440 million term loan and a $ 110 million revolving loan commitment. As of December 31, 2024, no additional amounts of revolving loans were available under the receivables financing facility. The Company has guaranteed the performance of the obligations of existing and future subsidiaries that sell and service the accounts receivable under the receivables financing facility. The assets of the SPE are not available to satisfy any of the Company’s obligations or any obligations of its subsidiaries. As of December 31, 2024, approximately $ 1,609 million of the Company's trade accounts receivable and unbilled services were pledged as collateral to secure the facility. </context> | us-gaap:LineOfCredit |
On October 1, 2024, the Company amended its receivables financing facility to extend the term of the $ 550 million facility to October 1, 2027. Under the receivables financing facility, certain of the Company's accounts receivable are sold on a non-recourse basis by certain of the Company's consolidated subsidiaries (each, an “Originator”) to another of the Company's consolidated subsidiaries, a bankruptcy-remote special purpose entity (the “SPE”). The SPE obtained a term loan and revolving loan commitment from a third-party lender, secured by liens on the assets of the SPE, to finance the purchase of the accounts receivable, which includes a $ 440 million term loan and a $ 110 million revolving loan commitment. As of December 31, 2024, no additional amounts of revolving loans were available under the receivables financing facility. The Company has guaranteed the performance of the obligations of existing and future subsidiaries that sell and service the accounts receivable under the receivables financing facility. The assets of the SPE are not available to satisfy any of the Company’s obligations or any obligations of its subsidiaries. As of December 31, 2024, approximately $ 1,609 million of the Company's trade accounts receivable and unbilled services were pledged as collateral to secure the facility. | text | 110 | monetaryItemType | text: <entity> 110 </entity> <entity type> monetaryItemType </entity type> <context> On October 1, 2024, the Company amended its receivables financing facility to extend the term of the $ 550 million facility to October 1, 2027. Under the receivables financing facility, certain of the Company's accounts receivable are sold on a non-recourse basis by certain of the Company's consolidated subsidiaries (each, an “Originator”) to another of the Company's consolidated subsidiaries, a bankruptcy-remote special purpose entity (the “SPE”). The SPE obtained a term loan and revolving loan commitment from a third-party lender, secured by liens on the assets of the SPE, to finance the purchase of the accounts receivable, which includes a $ 440 million term loan and a $ 110 million revolving loan commitment. As of December 31, 2024, no additional amounts of revolving loans were available under the receivables financing facility. The Company has guaranteed the performance of the obligations of existing and future subsidiaries that sell and service the accounts receivable under the receivables financing facility. The assets of the SPE are not available to satisfy any of the Company’s obligations or any obligations of its subsidiaries. As of December 31, 2024, approximately $ 1,609 million of the Company's trade accounts receivable and unbilled services were pledged as collateral to secure the facility. </context> | us-gaap:LineOfCredit |
On January 10, 2017, Quintiles IMS Health Incorporated and IMS Software Services Ltd. (collectively “IQVIA Parties”), filed a lawsuit in the U.S. District Court for the District of New Jersey against Veeva Systems, Inc. (“Veeva”) alleging Veeva unlawfully used IQVIA Parties intellectual property to improve Veeva data offerings, to promote and market Veeva data offerings and to improve Veeva technology offerings. IQVIA Parties seek injunctive relief, appointment of a monitor, the award of compensatory and punitive damages and reimbursement of all litigation expenses, including reasonable attorneys’ fees and costs. On March 13, 2017, Veeva filed counterclaims alleging anticompetitive business practices in violation of the Sherman Act and state laws. Veeva claims damages in excess of $ 200 million, and is seeking punitive damages and litigation costs, including attorneys’ fees. The Company believes the counterclaims are without merit, rejects all counterclaims raised by Veeva and intends to vigorously defend IQVIA Parties’ position and pursue its claims against Veeva. Since the initial filings, the parties have filed additional litigations against each other, primarily concerning the use of IQVIA data with various other Veeva products. Trial has been continued from an early 2025 setting to a date to be determined by the Court. | text | 200 | monetaryItemType | text: <entity> 200 </entity> <entity type> monetaryItemType </entity type> <context> On January 10, 2017, Quintiles IMS Health Incorporated and IMS Software Services Ltd. (collectively “IQVIA Parties”), filed a lawsuit in the U.S. District Court for the District of New Jersey against Veeva Systems, Inc. (“Veeva”) alleging Veeva unlawfully used IQVIA Parties intellectual property to improve Veeva data offerings, to promote and market Veeva data offerings and to improve Veeva technology offerings. IQVIA Parties seek injunctive relief, appointment of a monitor, the award of compensatory and punitive damages and reimbursement of all litigation expenses, including reasonable attorneys’ fees and costs. On March 13, 2017, Veeva filed counterclaims alleging anticompetitive business practices in violation of the Sherman Act and state laws. Veeva claims damages in excess of $ 200 million, and is seeking punitive damages and litigation costs, including attorneys’ fees. The Company believes the counterclaims are without merit, rejects all counterclaims raised by Veeva and intends to vigorously defend IQVIA Parties’ position and pursue its claims against Veeva. Since the initial filings, the parties have filed additional litigations against each other, primarily concerning the use of IQVIA data with various other Veeva products. Trial has been continued from an early 2025 setting to a date to be determined by the Court. </context> | us-gaap:LossContingencyDamagesSoughtValue |
The Company is authorized to issue 1.0 million shares of preferred stock, $ 0.01 per share par value. No shares of preferred stock were issued and outstanding as of December 31, 2024 or 2023. | text | 1.0 | sharesItemType | text: <entity> 1.0 </entity> <entity type> sharesItemType </entity type> <context> The Company is authorized to issue 1.0 million shares of preferred stock, $ 0.01 per share par value. No shares of preferred stock were issued and outstanding as of December 31, 2024 or 2023. </context> | us-gaap:PreferredStockSharesAuthorized |
The Company is authorized to issue 1.0 million shares of preferred stock, $ 0.01 per share par value. No shares of preferred stock were issued and outstanding as of December 31, 2024 or 2023. | text | 0.01 | perShareItemType | text: <entity> 0.01 </entity> <entity type> perShareItemType </entity type> <context> The Company is authorized to issue 1.0 million shares of preferred stock, $ 0.01 per share par value. No shares of preferred stock were issued and outstanding as of December 31, 2024 or 2023. </context> | us-gaap:PreferredStockParOrStatedValuePerShare |
As of December 31, 2024, the Company had remaining authorization to repurchase up to $ 1,013 million of its common stock under the Repurchase Program. In addition, from time to time, the Company has repurchased and may continue to repurchase common stock through private or other transactions outside of the Repurchase Program. | text | 1013 | monetaryItemType | text: <entity> 1013 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company had remaining authorization to repurchase up to $ 1,013 million of its common stock under the Repurchase Program. In addition, from time to time, the Company has repurchased and may continue to repurchase common stock through private or other transactions outside of the Repurchase Program. </context> | us-gaap:StockRepurchaseProgramRemainingAuthorizedRepurchaseAmount1 |
The portion of goodwill deductible for income tax purposes was preliminarily assessed as $ 343 million and $ 379 million for the years ended December 31, 2024 and 2023, respectively. | text | 343 | monetaryItemType | text: <entity> 343 </entity> <entity type> monetaryItemType </entity type> <context> The portion of goodwill deductible for income tax purposes was preliminarily assessed as $ 343 million and $ 379 million for the years ended December 31, 2024 and 2023, respectively. </context> | us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount |
The portion of goodwill deductible for income tax purposes was preliminarily assessed as $ 343 million and $ 379 million for the years ended December 31, 2024 and 2023, respectively. | text | 379 | monetaryItemType | text: <entity> 379 </entity> <entity type> monetaryItemType </entity type> <context> The portion of goodwill deductible for income tax purposes was preliminarily assessed as $ 343 million and $ 379 million for the years ended December 31, 2024 and 2023, respectively. </context> | us-gaap:BusinessAcquisitionPurchasePriceAllocationGoodwillExpectedTaxDeductibleAmount |
The management approved plans resulted in $ 67 million, $ 84 million and $ 28 million of restructuring expense, net of reversals, which consisted primarily of severance and other exit-related costs in the years ended December 31, 2024, 2023 and 2022, respectively. | text | 67 | monetaryItemType | text: <entity> 67 </entity> <entity type> monetaryItemType </entity type> <context> The management approved plans resulted in $ 67 million, $ 84 million and $ 28 million of restructuring expense, net of reversals, which consisted primarily of severance and other exit-related costs in the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:RestructuringCharges |
The management approved plans resulted in $ 67 million, $ 84 million and $ 28 million of restructuring expense, net of reversals, which consisted primarily of severance and other exit-related costs in the years ended December 31, 2024, 2023 and 2022, respectively. | text | 84 | monetaryItemType | text: <entity> 84 </entity> <entity type> monetaryItemType </entity type> <context> The management approved plans resulted in $ 67 million, $ 84 million and $ 28 million of restructuring expense, net of reversals, which consisted primarily of severance and other exit-related costs in the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:RestructuringCharges |
The management approved plans resulted in $ 67 million, $ 84 million and $ 28 million of restructuring expense, net of reversals, which consisted primarily of severance and other exit-related costs in the years ended December 31, 2024, 2023 and 2022, respectively. | text | 28 | monetaryItemType | text: <entity> 28 </entity> <entity type> monetaryItemType </entity type> <context> The management approved plans resulted in $ 67 million, $ 84 million and $ 28 million of restructuring expense, net of reversals, which consisted primarily of severance and other exit-related costs in the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:RestructuringCharges |
The Company's effective income tax rate was 18.0 %, 6.9 %, and 19.1 % for the years ending December 31, 2024, 2023, and 2022, respectively. The Company's effective income tax rate for December 31, 2023, was favorably impacted due to the completion of an internal legal entity restructuring that resulted in a benefit of $ 125 million. Historically, the Company recorded deferred tax assets related to certain foreign tax credits, and a full valuation allowance in relation to these foreign tax credits was established as it was not expected the credits would be utilized prior to expiration. The Company now believes it is reasonably possible that these foreign tax credits will be utilized and therefore recorded a tax benefit of $ 64 million related to the valuation allowance release and establishing related uncertain tax positions. Additionally, due to the restructuring the Company also reversed a deferred tax liability of $ 61 million due to a basis difference that was recovered in a tax-free manner. The effective tax rate was also favorably impacted by a reversal of uncertain tax positions relating to tax credit carryforwards in the amount of $ 21 million due to an audit settlement. | text | 18.0 | percentItemType | text: <entity> 18.0 </entity> <entity type> percentItemType </entity type> <context> The Company's effective income tax rate was 18.0 %, 6.9 %, and 19.1 % for the years ending December 31, 2024, 2023, and 2022, respectively. The Company's effective income tax rate for December 31, 2023, was favorably impacted due to the completion of an internal legal entity restructuring that resulted in a benefit of $ 125 million. Historically, the Company recorded deferred tax assets related to certain foreign tax credits, and a full valuation allowance in relation to these foreign tax credits was established as it was not expected the credits would be utilized prior to expiration. The Company now believes it is reasonably possible that these foreign tax credits will be utilized and therefore recorded a tax benefit of $ 64 million related to the valuation allowance release and establishing related uncertain tax positions. Additionally, due to the restructuring the Company also reversed a deferred tax liability of $ 61 million due to a basis difference that was recovered in a tax-free manner. The effective tax rate was also favorably impacted by a reversal of uncertain tax positions relating to tax credit carryforwards in the amount of $ 21 million due to an audit settlement. </context> | us-gaap:EffectiveIncomeTaxRateReconciliationFdiiPercent |
The Company's effective income tax rate was 18.0 %, 6.9 %, and 19.1 % for the years ending December 31, 2024, 2023, and 2022, respectively. The Company's effective income tax rate for December 31, 2023, was favorably impacted due to the completion of an internal legal entity restructuring that resulted in a benefit of $ 125 million. Historically, the Company recorded deferred tax assets related to certain foreign tax credits, and a full valuation allowance in relation to these foreign tax credits was established as it was not expected the credits would be utilized prior to expiration. The Company now believes it is reasonably possible that these foreign tax credits will be utilized and therefore recorded a tax benefit of $ 64 million related to the valuation allowance release and establishing related uncertain tax positions. Additionally, due to the restructuring the Company also reversed a deferred tax liability of $ 61 million due to a basis difference that was recovered in a tax-free manner. The effective tax rate was also favorably impacted by a reversal of uncertain tax positions relating to tax credit carryforwards in the amount of $ 21 million due to an audit settlement. | text | 6.9 | percentItemType | text: <entity> 6.9 </entity> <entity type> percentItemType </entity type> <context> The Company's effective income tax rate was 18.0 %, 6.9 %, and 19.1 % for the years ending December 31, 2024, 2023, and 2022, respectively. The Company's effective income tax rate for December 31, 2023, was favorably impacted due to the completion of an internal legal entity restructuring that resulted in a benefit of $ 125 million. Historically, the Company recorded deferred tax assets related to certain foreign tax credits, and a full valuation allowance in relation to these foreign tax credits was established as it was not expected the credits would be utilized prior to expiration. The Company now believes it is reasonably possible that these foreign tax credits will be utilized and therefore recorded a tax benefit of $ 64 million related to the valuation allowance release and establishing related uncertain tax positions. Additionally, due to the restructuring the Company also reversed a deferred tax liability of $ 61 million due to a basis difference that was recovered in a tax-free manner. The effective tax rate was also favorably impacted by a reversal of uncertain tax positions relating to tax credit carryforwards in the amount of $ 21 million due to an audit settlement. </context> | us-gaap:EffectiveIncomeTaxRateReconciliationFdiiPercent |
The Company's effective income tax rate was 18.0 %, 6.9 %, and 19.1 % for the years ending December 31, 2024, 2023, and 2022, respectively. The Company's effective income tax rate for December 31, 2023, was favorably impacted due to the completion of an internal legal entity restructuring that resulted in a benefit of $ 125 million. Historically, the Company recorded deferred tax assets related to certain foreign tax credits, and a full valuation allowance in relation to these foreign tax credits was established as it was not expected the credits would be utilized prior to expiration. The Company now believes it is reasonably possible that these foreign tax credits will be utilized and therefore recorded a tax benefit of $ 64 million related to the valuation allowance release and establishing related uncertain tax positions. Additionally, due to the restructuring the Company also reversed a deferred tax liability of $ 61 million due to a basis difference that was recovered in a tax-free manner. The effective tax rate was also favorably impacted by a reversal of uncertain tax positions relating to tax credit carryforwards in the amount of $ 21 million due to an audit settlement. | text | 19.1 | percentItemType | text: <entity> 19.1 </entity> <entity type> percentItemType </entity type> <context> The Company's effective income tax rate was 18.0 %, 6.9 %, and 19.1 % for the years ending December 31, 2024, 2023, and 2022, respectively. The Company's effective income tax rate for December 31, 2023, was favorably impacted due to the completion of an internal legal entity restructuring that resulted in a benefit of $ 125 million. Historically, the Company recorded deferred tax assets related to certain foreign tax credits, and a full valuation allowance in relation to these foreign tax credits was established as it was not expected the credits would be utilized prior to expiration. The Company now believes it is reasonably possible that these foreign tax credits will be utilized and therefore recorded a tax benefit of $ 64 million related to the valuation allowance release and establishing related uncertain tax positions. Additionally, due to the restructuring the Company also reversed a deferred tax liability of $ 61 million due to a basis difference that was recovered in a tax-free manner. The effective tax rate was also favorably impacted by a reversal of uncertain tax positions relating to tax credit carryforwards in the amount of $ 21 million due to an audit settlement. </context> | us-gaap:EffectiveIncomeTaxRateReconciliationFdiiPercent |
The Company's effective income tax rate was 18.0 %, 6.9 %, and 19.1 % for the years ending December 31, 2024, 2023, and 2022, respectively. The Company's effective income tax rate for December 31, 2023, was favorably impacted due to the completion of an internal legal entity restructuring that resulted in a benefit of $ 125 million. Historically, the Company recorded deferred tax assets related to certain foreign tax credits, and a full valuation allowance in relation to these foreign tax credits was established as it was not expected the credits would be utilized prior to expiration. The Company now believes it is reasonably possible that these foreign tax credits will be utilized and therefore recorded a tax benefit of $ 64 million related to the valuation allowance release and establishing related uncertain tax positions. Additionally, due to the restructuring the Company also reversed a deferred tax liability of $ 61 million due to a basis difference that was recovered in a tax-free manner. The effective tax rate was also favorably impacted by a reversal of uncertain tax positions relating to tax credit carryforwards in the amount of $ 21 million due to an audit settlement. | text | 21 | monetaryItemType | text: <entity> 21 </entity> <entity type> monetaryItemType </entity type> <context> The Company's effective income tax rate was 18.0 %, 6.9 %, and 19.1 % for the years ending December 31, 2024, 2023, and 2022, respectively. The Company's effective income tax rate for December 31, 2023, was favorably impacted due to the completion of an internal legal entity restructuring that resulted in a benefit of $ 125 million. Historically, the Company recorded deferred tax assets related to certain foreign tax credits, and a full valuation allowance in relation to these foreign tax credits was established as it was not expected the credits would be utilized prior to expiration. The Company now believes it is reasonably possible that these foreign tax credits will be utilized and therefore recorded a tax benefit of $ 64 million related to the valuation allowance release and establishing related uncertain tax positions. Additionally, due to the restructuring the Company also reversed a deferred tax liability of $ 61 million due to a basis difference that was recovered in a tax-free manner. The effective tax rate was also favorably impacted by a reversal of uncertain tax positions relating to tax credit carryforwards in the amount of $ 21 million due to an audit settlement. </context> | us-gaap:IncomeTaxReconciliationTaxSettlementsDomestic |
Undistributed earnings of the Company’s foreign subsidiaries amounted to approximately $ 5,117 million as of December 31, 2024. The Company does not consider any of its foreign earnings as indefinitely reinvested. | text | 5117 | monetaryItemType | text: <entity> 5117 </entity> <entity type> monetaryItemType </entity type> <context> Undistributed earnings of the Company’s foreign subsidiaries amounted to approximately $ 5,117 million as of December 31, 2024. The Company does not consider any of its foreign earnings as indefinitely reinvested. </context> | us-gaap:UndistributedEarningsOfForeignSubsidiaries |
In the year ended December 31, 2024, the Company increased its valuation allowance by $ 30 million to $ 196 million as of December 31, 2024 from $ 166 million as of December 31, 2023. On December 10, 2024, the US Department of Treasury published final regulations related to foreign currency gains and losses that are effective as of January 1, 2025. These regulations require computation of pre-transition foreign currency gain or loss to be included in the determination of future taxable income or loss. The valuation allowance increased primarily as a result of these regulations. We recorded a one-time, non-cash deferred tax benefit related to the pre-transition foreign currency losses in the current year that will be fully offset by a valuation allowance. | text | 30 | monetaryItemType | text: <entity> 30 </entity> <entity type> monetaryItemType </entity type> <context> In the year ended December 31, 2024, the Company increased its valuation allowance by $ 30 million to $ 196 million as of December 31, 2024 from $ 166 million as of December 31, 2023. On December 10, 2024, the US Department of Treasury published final regulations related to foreign currency gains and losses that are effective as of January 1, 2025. These regulations require computation of pre-transition foreign currency gain or loss to be included in the determination of future taxable income or loss. The valuation allowance increased primarily as a result of these regulations. We recorded a one-time, non-cash deferred tax benefit related to the pre-transition foreign currency losses in the current year that will be fully offset by a valuation allowance. </context> | us-gaap:ValuationAllowancesAndReservesPeriodIncreaseDecrease |
In the year ended December 31, 2024, the Company increased its valuation allowance by $ 30 million to $ 196 million as of December 31, 2024 from $ 166 million as of December 31, 2023. On December 10, 2024, the US Department of Treasury published final regulations related to foreign currency gains and losses that are effective as of January 1, 2025. These regulations require computation of pre-transition foreign currency gain or loss to be included in the determination of future taxable income or loss. The valuation allowance increased primarily as a result of these regulations. We recorded a one-time, non-cash deferred tax benefit related to the pre-transition foreign currency losses in the current year that will be fully offset by a valuation allowance. | text | 196 | monetaryItemType | text: <entity> 196 </entity> <entity type> monetaryItemType </entity type> <context> In the year ended December 31, 2024, the Company increased its valuation allowance by $ 30 million to $ 196 million as of December 31, 2024 from $ 166 million as of December 31, 2023. On December 10, 2024, the US Department of Treasury published final regulations related to foreign currency gains and losses that are effective as of January 1, 2025. These regulations require computation of pre-transition foreign currency gain or loss to be included in the determination of future taxable income or loss. The valuation allowance increased primarily as a result of these regulations. We recorded a one-time, non-cash deferred tax benefit related to the pre-transition foreign currency losses in the current year that will be fully offset by a valuation allowance. </context> | us-gaap:DeferredTaxAssetsValuationAllowance |
In the year ended December 31, 2024, the Company increased its valuation allowance by $ 30 million to $ 196 million as of December 31, 2024 from $ 166 million as of December 31, 2023. On December 10, 2024, the US Department of Treasury published final regulations related to foreign currency gains and losses that are effective as of January 1, 2025. These regulations require computation of pre-transition foreign currency gain or loss to be included in the determination of future taxable income or loss. The valuation allowance increased primarily as a result of these regulations. We recorded a one-time, non-cash deferred tax benefit related to the pre-transition foreign currency losses in the current year that will be fully offset by a valuation allowance. | text | 166 | monetaryItemType | text: <entity> 166 </entity> <entity type> monetaryItemType </entity type> <context> In the year ended December 31, 2024, the Company increased its valuation allowance by $ 30 million to $ 196 million as of December 31, 2024 from $ 166 million as of December 31, 2023. On December 10, 2024, the US Department of Treasury published final regulations related to foreign currency gains and losses that are effective as of January 1, 2025. These regulations require computation of pre-transition foreign currency gain or loss to be included in the determination of future taxable income or loss. The valuation allowance increased primarily as a result of these regulations. We recorded a one-time, non-cash deferred tax benefit related to the pre-transition foreign currency losses in the current year that will be fully offset by a valuation allowance. </context> | us-gaap:DeferredTaxAssetsValuationAllowance |
As of December 31, 2024, the Company had total gross unrecognized income tax benefits of $ 132 million associated with over 100 jurisdictions in which the Company conducts business that, if recognized, would reduce the Company’s effective income tax rate. | text | 132 | monetaryItemType | text: <entity> 132 </entity> <entity type> monetaryItemType </entity type> <context> As of December 31, 2024, the Company had total gross unrecognized income tax benefits of $ 132 million associated with over 100 jurisdictions in which the Company conducts business that, if recognized, would reduce the Company’s effective income tax rate. </context> | us-gaap:UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate |
The Company’s policy for recording interest and penalties relating to uncertain income tax positions is to record them as a component of income tax expense in the accompanying consolidated statements of income. In the years ended December 31, 2024, 2023 and 2022, the amount of interest and penalties recorded as an addition to income tax expense in the accompanying consolidated statements of income was $ 6 million, $ — million and $ 2 million, respectively. As of December 31, 2024, and 2023, the Company had accrued approximately $ 26 million and $ 20 million, respectively, of interest and penalties. | text | 26 | monetaryItemType | text: <entity> 26 </entity> <entity type> monetaryItemType </entity type> <context> The Company’s policy for recording interest and penalties relating to uncertain income tax positions is to record them as a component of income tax expense in the accompanying consolidated statements of income. In the years ended December 31, 2024, 2023 and 2022, the amount of interest and penalties recorded as an addition to income tax expense in the accompanying consolidated statements of income was $ 6 million, $ — million and $ 2 million, respectively. As of December 31, 2024, and 2023, the Company had accrued approximately $ 26 million and $ 20 million, respectively, of interest and penalties. </context> | us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued |
The Company’s policy for recording interest and penalties relating to uncertain income tax positions is to record them as a component of income tax expense in the accompanying consolidated statements of income. In the years ended December 31, 2024, 2023 and 2022, the amount of interest and penalties recorded as an addition to income tax expense in the accompanying consolidated statements of income was $ 6 million, $ — million and $ 2 million, respectively. As of December 31, 2024, and 2023, the Company had accrued approximately $ 26 million and $ 20 million, respectively, of interest and penalties. | text | 20 | monetaryItemType | text: <entity> 20 </entity> <entity type> monetaryItemType </entity type> <context> The Company’s policy for recording interest and penalties relating to uncertain income tax positions is to record them as a component of income tax expense in the accompanying consolidated statements of income. In the years ended December 31, 2024, 2023 and 2022, the amount of interest and penalties recorded as an addition to income tax expense in the accompanying consolidated statements of income was $ 6 million, $ — million and $ 2 million, respectively. As of December 31, 2024, and 2023, the Company had accrued approximately $ 26 million and $ 20 million, respectively, of interest and penalties. </context> | us-gaap:UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued |
The Company believes that it is reasonably possible that a decrease of up to $ 8 million in gross unrecognized income tax benefits for federal, state and foreign exposure items may be necessary within the next 12 months due to lapse of statutes of limitations or uncertain tax positions being effectively settled. The Company believes that it is reasonably possible that a decrease of up to $ 13 million in gross unrecognized income tax benefits for foreign items may be necessary within the next 12 months due to payments. For the remaining uncertain income tax positions, it is difficult at this time to estimate the timing of the resolution. | text | 8 | monetaryItemType | text: <entity> 8 </entity> <entity type> monetaryItemType </entity type> <context> The Company believes that it is reasonably possible that a decrease of up to $ 8 million in gross unrecognized income tax benefits for federal, state and foreign exposure items may be necessary within the next 12 months due to lapse of statutes of limitations or uncertain tax positions being effectively settled. The Company believes that it is reasonably possible that a decrease of up to $ 13 million in gross unrecognized income tax benefits for foreign items may be necessary within the next 12 months due to payments. For the remaining uncertain income tax positions, it is difficult at this time to estimate the timing of the resolution. </context> | us-gaap:UnrecognizedTaxBenefits |
The Company believes that it is reasonably possible that a decrease of up to $ 8 million in gross unrecognized income tax benefits for federal, state and foreign exposure items may be necessary within the next 12 months due to lapse of statutes of limitations or uncertain tax positions being effectively settled. The Company believes that it is reasonably possible that a decrease of up to $ 13 million in gross unrecognized income tax benefits for foreign items may be necessary within the next 12 months due to payments. For the remaining uncertain income tax positions, it is difficult at this time to estimate the timing of the resolution. | text | 13 | monetaryItemType | text: <entity> 13 </entity> <entity type> monetaryItemType </entity type> <context> The Company believes that it is reasonably possible that a decrease of up to $ 8 million in gross unrecognized income tax benefits for federal, state and foreign exposure items may be necessary within the next 12 months due to lapse of statutes of limitations or uncertain tax positions being effectively settled. The Company believes that it is reasonably possible that a decrease of up to $ 13 million in gross unrecognized income tax benefits for foreign items may be necessary within the next 12 months due to payments. For the remaining uncertain income tax positions, it is difficult at this time to estimate the timing of the resolution. </context> | us-gaap:UnrecognizedTaxBenefits |
The Company expects to contribute approximately $ 30 million in required contributions to its pension and postretirement benefit plans during 2025. The Company may make additional contributions into its pension plans in 2025 depending on, among other factors, how the funded status of those plans change or in order to meet minimum funding requirements as set forth in employee benefit and tax laws, plus additional amounts the Company may deem to be appropriate. | text | 30 | monetaryItemType | text: <entity> 30 </entity> <entity type> monetaryItemType </entity type> <context> The Company expects to contribute approximately $ 30 million in required contributions to its pension and postretirement benefit plans during 2025. The Company may make additional contributions into its pension plans in 2025 depending on, among other factors, how the funded status of those plans change or in order to meet minimum funding requirements as set forth in employee benefit and tax laws, plus additional amounts the Company may deem to be appropriate. </context> | us-gaap:DefinedBenefitPlanExpectedFutureEmployerContributionsNextFiscalYear |
In the United States, the Company has a 401(k) plan under which the Company matches employee deferrals at varying percentages and specified limits of the employee’s salary. For the years ended December 31, 2024, 2023 and 2022, the Company expensed $ 80 million, $ 81 million and $ 74 million, respectively, related to matching contributions. | text | 80 | monetaryItemType | text: <entity> 80 </entity> <entity type> monetaryItemType </entity type> <context> In the United States, the Company has a 401(k) plan under which the Company matches employee deferrals at varying percentages and specified limits of the employee’s salary. For the years ended December 31, 2024, 2023 and 2022, the Company expensed $ 80 million, $ 81 million and $ 74 million, respectively, related to matching contributions. </context> | us-gaap:DefinedContributionPlanCostRecognized |
In the United States, the Company has a 401(k) plan under which the Company matches employee deferrals at varying percentages and specified limits of the employee’s salary. For the years ended December 31, 2024, 2023 and 2022, the Company expensed $ 80 million, $ 81 million and $ 74 million, respectively, related to matching contributions. | text | 81 | monetaryItemType | text: <entity> 81 </entity> <entity type> monetaryItemType </entity type> <context> In the United States, the Company has a 401(k) plan under which the Company matches employee deferrals at varying percentages and specified limits of the employee’s salary. For the years ended December 31, 2024, 2023 and 2022, the Company expensed $ 80 million, $ 81 million and $ 74 million, respectively, related to matching contributions. </context> | us-gaap:DefinedContributionPlanCostRecognized |
In the United States, the Company has a 401(k) plan under which the Company matches employee deferrals at varying percentages and specified limits of the employee’s salary. For the years ended December 31, 2024, 2023 and 2022, the Company expensed $ 80 million, $ 81 million and $ 74 million, respectively, related to matching contributions. | text | 74 | monetaryItemType | text: <entity> 74 </entity> <entity type> monetaryItemType </entity type> <context> In the United States, the Company has a 401(k) plan under which the Company matches employee deferrals at varying percentages and specified limits of the employee’s salary. For the years ended December 31, 2024, 2023 and 2022, the Company expensed $ 80 million, $ 81 million and $ 74 million, respectively, related to matching contributions. </context> | us-gaap:DefinedContributionPlanCostRecognized |
The Company recognized stock-based compensation expense of $ 206 million, $ 217 million and $ 194 million in the years ended December 31, 2024, 2023 and 2022, respectively. Stock-based compensation expense is included in selling, general and administrative expenses on the accompanying consolidated statements of income. The associated future income tax benefit recognized was $ 36 million, $ 34 million and $ 28 million in the years ended December 31, 2024, 2023 and 2022, respectively. As of December 31, 2024, there was approximately $ 215 million of total unrecognized stock-based compensation expense related to outstanding non-vested stock-based compensation arrangements, which the Company expects to recognize over a weighted average period of 1.2 years. | text | 206 | monetaryItemType | text: <entity> 206 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognized stock-based compensation expense of $ 206 million, $ 217 million and $ 194 million in the years ended December 31, 2024, 2023 and 2022, respectively. Stock-based compensation expense is included in selling, general and administrative expenses on the accompanying consolidated statements of income. The associated future income tax benefit recognized was $ 36 million, $ 34 million and $ 28 million in the years ended December 31, 2024, 2023 and 2022, respectively. As of December 31, 2024, there was approximately $ 215 million of total unrecognized stock-based compensation expense related to outstanding non-vested stock-based compensation arrangements, which the Company expects to recognize over a weighted average period of 1.2 years. </context> | us-gaap:ShareBasedCompensation |
The Company recognized stock-based compensation expense of $ 206 million, $ 217 million and $ 194 million in the years ended December 31, 2024, 2023 and 2022, respectively. Stock-based compensation expense is included in selling, general and administrative expenses on the accompanying consolidated statements of income. The associated future income tax benefit recognized was $ 36 million, $ 34 million and $ 28 million in the years ended December 31, 2024, 2023 and 2022, respectively. As of December 31, 2024, there was approximately $ 215 million of total unrecognized stock-based compensation expense related to outstanding non-vested stock-based compensation arrangements, which the Company expects to recognize over a weighted average period of 1.2 years. | text | 217 | monetaryItemType | text: <entity> 217 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognized stock-based compensation expense of $ 206 million, $ 217 million and $ 194 million in the years ended December 31, 2024, 2023 and 2022, respectively. Stock-based compensation expense is included in selling, general and administrative expenses on the accompanying consolidated statements of income. The associated future income tax benefit recognized was $ 36 million, $ 34 million and $ 28 million in the years ended December 31, 2024, 2023 and 2022, respectively. As of December 31, 2024, there was approximately $ 215 million of total unrecognized stock-based compensation expense related to outstanding non-vested stock-based compensation arrangements, which the Company expects to recognize over a weighted average period of 1.2 years. </context> | us-gaap:ShareBasedCompensation |
The Company recognized stock-based compensation expense of $ 206 million, $ 217 million and $ 194 million in the years ended December 31, 2024, 2023 and 2022, respectively. Stock-based compensation expense is included in selling, general and administrative expenses on the accompanying consolidated statements of income. The associated future income tax benefit recognized was $ 36 million, $ 34 million and $ 28 million in the years ended December 31, 2024, 2023 and 2022, respectively. As of December 31, 2024, there was approximately $ 215 million of total unrecognized stock-based compensation expense related to outstanding non-vested stock-based compensation arrangements, which the Company expects to recognize over a weighted average period of 1.2 years. | text | 194 | monetaryItemType | text: <entity> 194 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognized stock-based compensation expense of $ 206 million, $ 217 million and $ 194 million in the years ended December 31, 2024, 2023 and 2022, respectively. Stock-based compensation expense is included in selling, general and administrative expenses on the accompanying consolidated statements of income. The associated future income tax benefit recognized was $ 36 million, $ 34 million and $ 28 million in the years ended December 31, 2024, 2023 and 2022, respectively. As of December 31, 2024, there was approximately $ 215 million of total unrecognized stock-based compensation expense related to outstanding non-vested stock-based compensation arrangements, which the Company expects to recognize over a weighted average period of 1.2 years. </context> | us-gaap:ShareBasedCompensation |
The Company recognized stock-based compensation expense of $ 206 million, $ 217 million and $ 194 million in the years ended December 31, 2024, 2023 and 2022, respectively. Stock-based compensation expense is included in selling, general and administrative expenses on the accompanying consolidated statements of income. The associated future income tax benefit recognized was $ 36 million, $ 34 million and $ 28 million in the years ended December 31, 2024, 2023 and 2022, respectively. As of December 31, 2024, there was approximately $ 215 million of total unrecognized stock-based compensation expense related to outstanding non-vested stock-based compensation arrangements, which the Company expects to recognize over a weighted average period of 1.2 years. | text | 36 | monetaryItemType | text: <entity> 36 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognized stock-based compensation expense of $ 206 million, $ 217 million and $ 194 million in the years ended December 31, 2024, 2023 and 2022, respectively. Stock-based compensation expense is included in selling, general and administrative expenses on the accompanying consolidated statements of income. The associated future income tax benefit recognized was $ 36 million, $ 34 million and $ 28 million in the years ended December 31, 2024, 2023 and 2022, respectively. As of December 31, 2024, there was approximately $ 215 million of total unrecognized stock-based compensation expense related to outstanding non-vested stock-based compensation arrangements, which the Company expects to recognize over a weighted average period of 1.2 years. </context> | us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense |
The Company recognized stock-based compensation expense of $ 206 million, $ 217 million and $ 194 million in the years ended December 31, 2024, 2023 and 2022, respectively. Stock-based compensation expense is included in selling, general and administrative expenses on the accompanying consolidated statements of income. The associated future income tax benefit recognized was $ 36 million, $ 34 million and $ 28 million in the years ended December 31, 2024, 2023 and 2022, respectively. As of December 31, 2024, there was approximately $ 215 million of total unrecognized stock-based compensation expense related to outstanding non-vested stock-based compensation arrangements, which the Company expects to recognize over a weighted average period of 1.2 years. | text | 34 | monetaryItemType | text: <entity> 34 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognized stock-based compensation expense of $ 206 million, $ 217 million and $ 194 million in the years ended December 31, 2024, 2023 and 2022, respectively. Stock-based compensation expense is included in selling, general and administrative expenses on the accompanying consolidated statements of income. The associated future income tax benefit recognized was $ 36 million, $ 34 million and $ 28 million in the years ended December 31, 2024, 2023 and 2022, respectively. As of December 31, 2024, there was approximately $ 215 million of total unrecognized stock-based compensation expense related to outstanding non-vested stock-based compensation arrangements, which the Company expects to recognize over a weighted average period of 1.2 years. </context> | us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense |
The Company recognized stock-based compensation expense of $ 206 million, $ 217 million and $ 194 million in the years ended December 31, 2024, 2023 and 2022, respectively. Stock-based compensation expense is included in selling, general and administrative expenses on the accompanying consolidated statements of income. The associated future income tax benefit recognized was $ 36 million, $ 34 million and $ 28 million in the years ended December 31, 2024, 2023 and 2022, respectively. As of December 31, 2024, there was approximately $ 215 million of total unrecognized stock-based compensation expense related to outstanding non-vested stock-based compensation arrangements, which the Company expects to recognize over a weighted average period of 1.2 years. | text | 28 | monetaryItemType | text: <entity> 28 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognized stock-based compensation expense of $ 206 million, $ 217 million and $ 194 million in the years ended December 31, 2024, 2023 and 2022, respectively. Stock-based compensation expense is included in selling, general and administrative expenses on the accompanying consolidated statements of income. The associated future income tax benefit recognized was $ 36 million, $ 34 million and $ 28 million in the years ended December 31, 2024, 2023 and 2022, respectively. As of December 31, 2024, there was approximately $ 215 million of total unrecognized stock-based compensation expense related to outstanding non-vested stock-based compensation arrangements, which the Company expects to recognize over a weighted average period of 1.2 years. </context> | us-gaap:EmployeeServiceShareBasedCompensationTaxBenefitFromCompensationExpense |
The Company recognized stock-based compensation expense of $ 206 million, $ 217 million and $ 194 million in the years ended December 31, 2024, 2023 and 2022, respectively. Stock-based compensation expense is included in selling, general and administrative expenses on the accompanying consolidated statements of income. The associated future income tax benefit recognized was $ 36 million, $ 34 million and $ 28 million in the years ended December 31, 2024, 2023 and 2022, respectively. As of December 31, 2024, there was approximately $ 215 million of total unrecognized stock-based compensation expense related to outstanding non-vested stock-based compensation arrangements, which the Company expects to recognize over a weighted average period of 1.2 years. | text | 215 | monetaryItemType | text: <entity> 215 </entity> <entity type> monetaryItemType </entity type> <context> The Company recognized stock-based compensation expense of $ 206 million, $ 217 million and $ 194 million in the years ended December 31, 2024, 2023 and 2022, respectively. Stock-based compensation expense is included in selling, general and administrative expenses on the accompanying consolidated statements of income. The associated future income tax benefit recognized was $ 36 million, $ 34 million and $ 28 million in the years ended December 31, 2024, 2023 and 2022, respectively. As of December 31, 2024, there was approximately $ 215 million of total unrecognized stock-based compensation expense related to outstanding non-vested stock-based compensation arrangements, which the Company expects to recognize over a weighted average period of 1.2 years. </context> | us-gaap:EmployeeServiceShareBasedCompensationNonvestedAwardsTotalCompensationCostNotYetRecognized |
As of December 31, 2024, there were 7.6 million shares available for future grants under all of the Company’s stock incentive plans. | text | 7.6 | sharesItemType | text: <entity> 7.6 </entity> <entity type> sharesItemType </entity type> <context> As of December 31, 2024, there were 7.6 million shares available for future grants under all of the Company’s stock incentive plans. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAvailableForGrant |
The weighted average fair value per share of SSRs granted in the year ended December 31, 2024 was $ 70.63 . The total intrinsic value of SSRs exercised was approximately $ 88 million, $ 51 million and $ 25 million in the years ended December 31, 2024, 2023 and 2022, respectively. | text | 70.63 | perShareItemType | text: <entity> 70.63 </entity> <entity type> perShareItemType </entity type> <context> The weighted average fair value per share of SSRs granted in the year ended December 31, 2024 was $ 70.63 . The total intrinsic value of SSRs exercised was approximately $ 88 million, $ 51 million and $ 25 million in the years ended December 31, 2024, 2023 and 2022, respectively. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageGrantDateFairValue |
The total intrinsic value of options exercised was approximately $ 15 million, $ 23 million and $ 9 million in the years ended December 31, 2024, 2023 and 2022, respectively. The Company received cash of approximately $ 5 million, $ 7 million and $ 2 million in 2024, 2023, and 2022, respectively, from options exercised. | text | 15 | monetaryItemType | text: <entity> 15 </entity> <entity type> monetaryItemType </entity type> <context> The total intrinsic value of options exercised was approximately $ 15 million, $ 23 million and $ 9 million in the years ended December 31, 2024, 2023 and 2022, respectively. The Company received cash of approximately $ 5 million, $ 7 million and $ 2 million in 2024, 2023, and 2022, respectively, from options exercised. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue |
The total intrinsic value of options exercised was approximately $ 15 million, $ 23 million and $ 9 million in the years ended December 31, 2024, 2023 and 2022, respectively. The Company received cash of approximately $ 5 million, $ 7 million and $ 2 million in 2024, 2023, and 2022, respectively, from options exercised. | text | 23 | monetaryItemType | text: <entity> 23 </entity> <entity type> monetaryItemType </entity type> <context> The total intrinsic value of options exercised was approximately $ 15 million, $ 23 million and $ 9 million in the years ended December 31, 2024, 2023 and 2022, respectively. The Company received cash of approximately $ 5 million, $ 7 million and $ 2 million in 2024, 2023, and 2022, respectively, from options exercised. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue |
The total intrinsic value of options exercised was approximately $ 15 million, $ 23 million and $ 9 million in the years ended December 31, 2024, 2023 and 2022, respectively. The Company received cash of approximately $ 5 million, $ 7 million and $ 2 million in 2024, 2023, and 2022, respectively, from options exercised. | text | 9 | monetaryItemType | text: <entity> 9 </entity> <entity type> monetaryItemType </entity type> <context> The total intrinsic value of options exercised was approximately $ 15 million, $ 23 million and $ 9 million in the years ended December 31, 2024, 2023 and 2022, respectively. The Company received cash of approximately $ 5 million, $ 7 million and $ 2 million in 2024, 2023, and 2022, respectively, from options exercised. </context> | us-gaap:ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisesInPeriodTotalIntrinsicValue |
The total intrinsic value of options exercised was approximately $ 15 million, $ 23 million and $ 9 million in the years ended December 31, 2024, 2023 and 2022, respectively. The Company received cash of approximately $ 5 million, $ 7 million and $ 2 million in 2024, 2023, and 2022, respectively, from options exercised. | text | 5 | monetaryItemType | text: <entity> 5 </entity> <entity type> monetaryItemType </entity type> <context> The total intrinsic value of options exercised was approximately $ 15 million, $ 23 million and $ 9 million in the years ended December 31, 2024, 2023 and 2022, respectively. The Company received cash of approximately $ 5 million, $ 7 million and $ 2 million in 2024, 2023, and 2022, respectively, from options exercised. </context> | us-gaap:ProceedsFromStockOptionsExercised |
Subsets and Splits
No community queries yet
The top public SQL queries from the community will appear here once available.